CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | gold atom |
|
Accession: | CHEBI:29287
|
browse the term
|
Definition: | A copper group element atom that has formula Au. |
Synonyms: | related_synonym: | 79Au; Au; Formula=Au; Gold; InChI=1S/Au; InChIKey=PCHJSUWPFVWCPO-UHFFFAOYSA-N; SMILES=[Au]; aurum; or; oro |
| xref: | CAS:7440-57-5 |
| xref_mesh: | MESH:D006046 |
| xref: | WebElements:Au |
|
|
|
G |
4931406C07Rik |
RIKEN cDNA 4931406C07 gene |
decreases expression |
ISO |
Gold results in decreased expression of C11ORF54 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 9:15,194,633...15,217,836
Ensembl chr 9:15,194,633...15,217,744
|
|
G |
Aass |
aminoadipate-semialdehyde synthase |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of AASS mRNA Gold analog results in decreased expression of AASS mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr 6:23,072,172...23,132,985
Ensembl chr 6:23,072,172...23,132,985
|
|
G |
Abcb1a |
ATP-binding cassette, sub-family B member 1A |
increases expression |
ISO |
Gold analog results in increased expression of ABCB1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
|
|
G |
Abcb4 |
ATP-binding cassette, sub-family B member 4 |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of ABCB4 mRNA Gold analog results in decreased expression of ABCB4 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr 5:8,943,614...9,009,226
Ensembl chr 5:8,943,717...9,009,231
|
|
G |
Abcc1 |
ATP-binding cassette, sub-family C member 1 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of ABCC1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr16:14,179,317...14,292,743
Ensembl chr16:14,179,422...14,293,601
|
|
G |
Abcc2 |
ATP-binding cassette, sub-family member 2 |
increases expression |
ISO |
Gold analog results in increased expression of ABCC2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr19:43,770,747...43,826,771
Ensembl chr19:43,770,631...43,829,179
|
|
G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of ABL1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 2:31,578,256...31,697,105
Ensembl chr 2:31,578,388...31,694,239
|
|
G |
Acaa1b |
acetyl-Coenzyme A acyltransferase 1B |
decreases expression |
ISO |
Gold analog results in decreased expression of ACAA1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 9:118,977,111...118,986,149
Ensembl chr 9:118,977,091...118,986,161
|
|
G |
Acaca |
acetyl-Coenzyme A carboxylase alpha |
decreases expression |
ISO |
Gold analog results in decreased expression of ACACA mRNA |
CTD |
PMID:36057382 |
|
NCBI chr11:84,020,461...84,292,477
Ensembl chr11:84,020,498...84,292,477
|
|
G |
Acad11 |
acyl-Coenzyme A dehydrogenase family, member 11 |
decreases expression |
ISO |
Gold analog results in decreased expression of ACAD11 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 9:103,940,923...104,004,855
Ensembl chr 9:103,940,576...104,004,924
|
|
G |
Acadm |
acyl-Coenzyme A dehydrogenase, medium chain |
decreases expression |
ISO |
Gold analog results in decreased expression of ACADM mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 3:153,627,990...153,650,280
Ensembl chr 3:153,627,994...153,650,269
|
|
G |
Acads |
acyl-Coenzyme A dehydrogenase, short chain |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of ACADS mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 5:115,248,358...115,257,405
Ensembl chr 5:115,248,358...115,257,405
|
|
G |
Acadvl |
acyl-Coenzyme A dehydrogenase, very long chain |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of ACADVL mRNA |
CTD |
PMID:28433809 |
|
NCBI chr11:69,901,009...69,906,254
Ensembl chr11:69,901,009...69,906,237
|
|
G |
Acnat2 |
acyl-coenzyme A amino acid N-acyltransferase 2 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of ACNAT2 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 4:49,374,458...49,408,151
Ensembl chr 4:49,379,840...49,408,151
|
|
G |
Aco1 |
aconitase 1 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in increased expression of ACO1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 4:40,143,429...40,199,011
Ensembl chr 4:40,143,081...40,198,338
|
|
G |
Aco2 |
aconitase 2, mitochondrial |
decreases expression multiple interactions |
EXP ISO |
Gold analog results in decreased expression of ACO2 protein [Polyethyleneimine binds to Gold] which results in increased expression of ACO2 mRNA |
CTD |
PMID:24780912 PMID:28433809 |
|
NCBI chr15:81,756,664...81,799,338
Ensembl chr15:81,756,510...81,799,334
|
|
G |
Acox1 |
acyl-Coenzyme A oxidase 1, palmitoyl |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of ACOX1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr11:116,062,714...116,089,605
Ensembl chr11:116,062,714...116,089,871
|
|
G |
Acox2 |
acyl-Coenzyme A oxidase 2, branched chain |
decreases expression |
ISO |
Gold analog results in decreased expression of ACOX2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr14:14,210,406...14,244,262
Ensembl chr14:14,210,420...14,244,262
|
|
G |
Acp1 |
acid phosphatase 1, soluble |
decreases expression |
ISO |
Gold results in decreased expression of ACP1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr12:30,943,325...30,961,616
Ensembl chr12:30,943,325...30,961,588
|
|
G |
Acvr1c |
activin A receptor, type IC |
decreases expression |
ISO |
Gold results in decreased expression of ACVR1C mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:58,157,465...58,247,909
Ensembl chr 2:58,157,465...58,247,907
|
|
G |
Adam28 |
a disintegrin and metallopeptidase domain 28 |
increases expression |
ISO |
Gold results in increased expression of ADAM28 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr14:68,842,447...68,893,338
Ensembl chr14:68,843,476...68,893,291
|
|
G |
Adh5 |
alcohol dehydrogenase 5 (class III), chi polypeptide |
decreases expression |
ISO |
Gold results in decreased expression of ADH5 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:138,142,961...138,161,260
Ensembl chr 3:138,148,854...138,161,260
|
|
G |
Adipor2 |
adiponectin receptor 2 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of ADIPOR2 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 6:119,330,111...119,394,489
Ensembl chr 6:119,330,111...119,394,665
|
|
G |
Adra1b |
adrenergic receptor, alpha 1b |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of ADRA1B mRNA |
CTD |
PMID:19695318 |
|
NCBI chr11:43,665,432...43,792,076
Ensembl chr11:43,665,433...43,792,037
|
|
G |
Adrb2 |
adrenergic receptor, beta 2 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of ADRB2 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr18:62,310,784...62,313,052
Ensembl chr18:62,310,887...62,313,030
|
|
G |
Ahsg |
alpha-2-HS-glycoprotein |
decreases expression |
ISO |
Gold analog results in decreased expression of AHSG mRNA |
CTD |
PMID:36057382 |
|
NCBI chr16:22,710,793...22,718,193
Ensembl chr16:22,710,027...22,718,199
|
|
G |
Aifm1 |
apoptosis-inducing factor, mitochondrion-associated 1 |
increases expression |
ISO |
Gold results in increased expression of AIFM1 protein |
CTD |
PMID:25462594 |
|
NCBI chr X:47,563,821...47,602,440
Ensembl chr X:47,563,821...47,602,440
|
|
G |
Aimp1 |
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 |
decreases expression |
ISO |
Gold results in decreased expression of AIMP1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:132,366,259...132,390,151
Ensembl chr 3:132,366,242...132,390,131
|
|
G |
Ak3 |
adenylate kinase 3 |
decreases expression |
ISO |
Gold results in decreased expression of AK3 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr19:28,968,715...29,026,122
Ensembl chr19:28,998,233...29,025,361
|
|
G |
Akap13 |
A kinase anchor protein 13 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of AKAP13 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 7:75,105,271...75,404,357
Ensembl chr 7:75,105,282...75,404,357
|
|
G |
Akr1b10 |
aldo-keto reductase family 1, member B10 |
increases expression |
ISO |
Gold results in increased expression of AKR1B10 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 6:34,361,182...34,373,884
Ensembl chr 6:34,361,153...34,373,885
|
|
G |
Akr1c18 |
aldo-keto reductase family 1, member C18 |
increases expression |
ISO |
Gold results in increased expression of AKR1C3 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr13:4,182,614...4,200,645
Ensembl chr13:4,182,614...4,200,653
|
|
G |
Akr1c21 |
aldo-keto reductase family 1, member C21 |
increases expression |
ISO |
Gold results in increased expression of AKR1C2 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr13:4,624,074...4,636,542
Ensembl chr13:4,624,074...4,636,540
|
|
G |
Akt1 |
thymoma viral proto-oncogene 1 |
multiple interactions |
ISO |
[Quercetin analog co-treated with Gold analog] results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:27470402 |
|
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
|
|
G |
Alb |
albumin |
multiple interactions increases expression |
ISO |
ALB protein results in increased uptake of [Polyethylene Glycols binds to Gold]; ALB protein results in increased uptake of [Polyethyleneimine binds to Gold]; ALB protein results in increased uptake of [Thioctic Acid binds to Gold] Gold analog results in increased expression of ALB mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
|
|
G |
Anxa5 |
annexin A5 |
increases expression |
EXP |
Gold analog results in increased expression of ANXA5 protein |
CTD |
PMID:24780912 |
|
NCBI chr 3:36,503,072...36,530,036
Ensembl chr 3:36,503,072...36,530,043
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of APAF1 mRNA; [Quercetin analog co-treated with Gold analog] results in increased expression of APAF1 protein Gold analog results in decreased expression of APAF1 mRNA |
CTD |
PMID:27470402 PMID:28433809 PMID:36057382 |
|
NCBI chr10:90,825,173...90,918,688
Ensembl chr10:90,825,173...90,918,632
|
|
G |
Apex1 |
apurinic/apyrimidinic endonuclease 1 |
decreases expression |
ISO |
Gold analog results in decreased expression of APEX1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr14:51,162,406...51,164,645
Ensembl chr14:51,162,425...51,164,596
|
|
G |
Apoa4 |
apolipoprotein A-IV |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of APOA4 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 9:46,152,142...46,154,756
Ensembl chr 9:46,151,994...46,154,757
|
|
G |
Aprt |
adenine phosphoribosyl transferase |
decreases expression |
EXP |
Gold analog results in decreased expression of APRT protein |
CTD |
PMID:24780912 |
|
NCBI chr 8:123,301,376...123,303,646
Ensembl chr 8:123,301,374...123,303,648
|
|
G |
Aqp4 |
aquaporin 4 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of AQP4 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr18:15,522,451...15,544,039
Ensembl chr18:15,522,553...15,544,039
|
|
G |
Arl1 |
ADP-ribosylation factor-like 1 |
decreases expression |
ISO |
Gold results in decreased expression of ARL1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr10:88,566,720...88,579,956
Ensembl chr10:88,566,720...88,579,956
|
|
G |
Arl5b |
ADP-ribosylation factor-like 5B |
decreases expression |
ISO |
Gold results in decreased expression of ARL5B mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:15,060,066...15,087,267
Ensembl chr 2:15,054,206...15,087,267
|
|
G |
Arsg |
arylsulfatase G |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of ARSG mRNA |
CTD |
PMID:19695318 |
|
NCBI chr11:109,364,159...109,464,156
Ensembl chr11:109,364,200...109,464,156
|
|
G |
Asah1 |
N-acylsphingosine amidohydrolase 1 |
decreases expression |
ISO |
Gold analog results in decreased expression of ASAH1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 8:41,793,683...41,850,681
Ensembl chr 8:41,793,234...41,827,810
|
|
G |
Atf1 |
activating transcription factor 1 |
decreases expression |
ISO |
Gold results in decreased expression of ATF1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr15:100,125,729...100,159,129
Ensembl chr15:100,125,700...100,159,125
|
|
G |
Atf4 |
activating transcription factor 4 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of ATF4 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr15:80,139,385...80,141,746
Ensembl chr15:80,139,385...80,141,742
|
|
G |
Atf6 |
activating transcription factor 6 |
increases cleavage |
ISO |
Gold analog results in increased cleavage of ATF6 protein |
CTD |
PMID:26551149 |
|
NCBI chr 1:170,532,026...170,696,414
Ensembl chr 1:170,532,243...170,695,340
|
|
G |
Atic |
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase |
decreases expression |
EXP |
Gold analog results in decreased expression of ATIC protein |
CTD |
PMID:24780912 |
|
NCBI chr 1:71,596,315...71,618,562
Ensembl chr 1:71,596,309...71,618,790
|
|
G |
Atl2 |
atlastin GTPase 2 |
decreases expression |
ISO |
Gold results in decreased expression of ATL2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr17:80,155,819...80,203,633
Ensembl chr17:80,155,819...80,203,552
|
|
G |
Atm |
ataxia telangiectasia mutated |
decreases expression |
ISO |
Gold analog results in decreased expression of ATM mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 9:53,348,422...53,448,125
Ensembl chr 9:53,350,449...53,448,040
|
|
G |
Atp2b1 |
ATPase, Ca++ transporting, plasma membrane 1 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of ATP2B1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr10:98,750,243...98,862,005
Ensembl chr10:98,750,268...98,862,005
|
|
G |
Atp5f1b |
ATP synthase F1 subunit beta |
multiple interactions |
EXP |
Gold analog results in increased expression of and results in decreased phosphorylation of ATP5F1B protein |
CTD |
PMID:24780912 |
|
NCBI chr10:127,919,176...127,926,257
Ensembl chr10:127,919,142...127,926,260
|
|
G |
Atp6v1g2 |
ATPase, H+ transporting, lysosomal V1 subunit G2 |
decreases expression |
ISO |
Gold analog results in decreased expression of ATP6V1G2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr17:35,453,910...35,457,743
Ensembl chr17:35,452,636...35,457,743
|
|
G |
Atr |
ataxia telangiectasia and Rad3 related |
decreases expression |
ISO |
Gold analog results in decreased expression of ATR mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 9:95,739,655...95,834,813
Ensembl chr 9:95,739,650...95,833,834
|
|
G |
Bace1 |
beta-site APP cleaving enzyme 1 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of BACE1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 9:45,749,878...45,775,694
Ensembl chr 9:45,749,878...45,775,697
|
|
G |
Bad |
BCL2-associated agonist of cell death |
multiple interactions |
ISO |
[Quercetin analog co-treated with Gold analog] results in increased expression of BAD protein |
CTD |
PMID:27470402 |
|
NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267
|
|
G |
Baiap2 |
brain-specific angiogenesis inhibitor 1-associated protein 2 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of BAIAP2 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr11:119,833,762...119,897,608
Ensembl chr11:119,833,589...119,897,608
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
increases expression |
ISO |
Gold results in increased expression of BAK1 mRNA |
CTD |
PMID:22178767 |
|
NCBI chr17:27,238,786...27,247,601
Ensembl chr17:27,238,784...27,247,983
|
|
G |
Bax |
BCL2-associated X protein |
multiple interactions increases expression |
ISO |
[[Gold results in decreased abundance of Glutathione] which results in increased abundance of Hydrogen Peroxide] which affects the localization of BAX protein; [Gold analog co-treated with Platinum] results in increased expression of BAX mRNA; [Polyethyleneimine binds to Gold] which results in decreased expression of BAX mRNA; [Quercetin analog co-treated with Gold analog] results in increased expression of BAX protein [Gold binds to NKCT1 protein, Naja kaouthia] which results in increased expression of BAX protein Gold results in increased expression of BAX mRNA |
CTD |
PMID:21621595 PMID:22178767 PMID:25846798 PMID:27470402 PMID:27836789 PMID:28433809 More...
|
|
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
|
|
G |
Bcas2 |
BCAS2 pre-mRNA processing factor |
decreases expression |
ISO |
Gold results in decreased expression of BCAS2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:103,078,971...103,086,479
Ensembl chr 3:103,078,971...103,086,482
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
multiple interactions |
ISO |
[Gold analog co-treated with Platinum] results in decreased expression of BCL2 mRNA; [Quercetin analog co-treated with Gold analog] results in decreased expression of BCL2 protein [Gold binds to NKCT1 protein, Naja kaouthia] which results in decreased expression of BCL2 protein |
CTD |
PMID:25846798 PMID:27470402 PMID:27836789 |
|
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Bcl2l1 |
BCL2-like 1 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in increased expression of BCL2L1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
|
|
G |
Bcl2l11 |
BCL2 like 11 |
decreases expression |
ISO |
Gold analog results in decreased expression of BCL2L11 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 2:127,967,958...128,004,467
Ensembl chr 2:127,967,958...128,004,467
|
|
G |
Birc2 |
baculoviral IAP repeat-containing 2 |
decreases expression |
ISO |
Gold results in decreased expression of BIRC2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 9:7,818,227...7,837,123
Ensembl chr 9:7,818,228...7,837,065
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
decreases expression |
ISO |
Gold analog results in decreased expression of BIRC3 mRNA; Gold results in decreased expression of BIRC3 mRNA |
CTD |
PMID:25523186 PMID:36057382 |
|
NCBI chr 9:7,848,698...7,873,199
Ensembl chr 9:7,848,700...7,873,187
|
|
G |
Bmal1 |
basic helix-loop-helix ARNT like 1 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of BMAL1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 7:112,777,820...112,913,333
Ensembl chr 7:112,806,672...112,913,333
|
|
G |
Bmi1 |
Bmi1 polycomb ring finger oncogene |
decreases expression |
ISO |
Gold results in decreased expression of BMI1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:18,681,953...18,691,440
Ensembl chr 2:18,681,829...18,691,440
|
|
G |
Brca1 |
breast cancer 1, early onset |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of BRCA1 mRNA Gold analog results in decreased expression of BRCA1 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr11:101,379,587...101,442,808
Ensembl chr11:101,379,590...101,442,781
|
|
G |
Brca2 |
breast cancer 2, early onset |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of BRCA2 mRNA Gold analog results in decreased expression of BRCA2 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr 5:150,445,759...150,493,612
Ensembl chr 5:150,446,095...150,493,794
|
|
G |
C1d |
C1D nuclear receptor co-repressor |
decreases expression |
ISO |
Gold results in decreased expression of C1D mRNA |
CTD |
PMID:25523186 |
|
NCBI chr11:17,207,547...17,219,176
Ensembl chr11:17,207,579...17,219,176
|
|
G |
C3 |
complement component 3 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of C3 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
|
|
G |
C9 |
complement component 9 |
decreases expression |
ISO |
Gold analog results in decreased expression of C9 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr15:6,474,827...6,528,306
Ensembl chr15:6,474,808...6,528,232
|
|
G |
Capza2 |
capping actin protein of muscle Z-line subunit alpha 2 |
decreases expression |
ISO |
Gold results in decreased expression of CAPZA2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 6:17,637,009...17,666,971
Ensembl chr 6:17,636,233...17,666,971
|
|
G |
Car13 |
carbonic anhydrase 13 |
decreases expression |
ISO |
Gold results in decreased expression of CA13 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:14,706,787...14,728,062
Ensembl chr 3:14,706,787...14,728,062
|
|
G |
Casp1 |
caspase 1 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in increased expression of CASP1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 9:5,298,517...5,307,281
Ensembl chr 9:5,298,508...5,307,290
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity increases cleavage increases expression |
ISO |
[[Gold results in decreased abundance of Glutathione] which results in increased abundance of Hydrogen Peroxide] which results in increased activity of CASP3 protein; [Gold analog co-treated with Platinum] results in increased activity of CASP3 protein; [Gold analog co-treated with Platinum] results in increased expression of CASP3 mRNA; [Polyethyleneimine binds to Gold] which results in increased expression of CASP3 mRNA; [Quercetin analog co-treated with Gold analog] results in increased cleavage of CASP3 protein; [Quercetin analog co-treated with Gold analog] results in increased expression of and results in increased activity of CASP3 protein; Dexamethasone promotes the reaction [Gold results in increased activity of CASP3 protein]; Etoposide promotes the reaction [Gold results in increased activity of CASP3 protein] Gold analog results in increased cleavage of CASP3 protein [Gold binds to NKCT1 protein, Naja kaouthia] which results in increased expression of CASP3 protein Gold results in increased expression of CASP3 mRNA |
CTD |
PMID:19760634 PMID:21621595 PMID:22178767 PMID:25846798 PMID:26551149 PMID:27470402 PMID:27836789 PMID:28433809 More...
|
|
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Casp4 |
caspase 4, apoptosis-related cysteine peptidase |
increases cleavage |
ISO |
Gold analog results in increased cleavage of CASP4 protein |
CTD |
PMID:26551149 |
|
NCBI chr 9:5,308,816...5,336,791
Ensembl chr 9:5,308,828...5,336,783
|
|
G |
Casp7 |
caspase 7 |
increases cleavage |
ISO |
Gold analog results in increased cleavage of CASP7 protein |
CTD |
PMID:26551149 |
|
NCBI chr19:56,382,640...56,430,780
Ensembl chr19:56,385,561...56,430,776
|
|
G |
Casp8 |
caspase 8 |
increases expression decreases expression |
ISO |
Gold results in increased expression of CASP8 mRNA Gold analog results in decreased expression of CASP8 mRNA |
CTD |
PMID:22178767 PMID:36057382 |
|
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases cleavage |
ISO |
[Gold analog co-treated with Platinum] results in increased activity of CASP9 protein; [Gold analog co-treated with Platinum] results in increased expression of CASP9 mRNA Gold analog results in increased cleavage of CASP9 protein [Gold binds to NKCT1 protein, Naja kaouthia] which results in increased expression of CASP9 protein |
CTD |
PMID:25846798 PMID:26551149 PMID:27836789 |
|
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
|
|
G |
Cat |
catalase |
multiple interactions |
EXP |
[Gold binds to NKCT1 protein, Naja kaouthia] inhibits the reaction [Diethylnitrosamine results in decreased activity of CAT protein] |
CTD |
PMID:27836789 |
|
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
|
|
G |
Cbx3 |
chromobox 3 |
decreases expression |
ISO |
Gold results in decreased expression of CBX3 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 6:51,447,596...51,460,684
Ensembl chr 6:51,447,340...51,460,684
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions increases secretion |
EXP |
[Gold co-treated with Silicon Dioxide] results in increased secretion of CCL2 protein Gold results in increased secretion of CCL2 protein |
CTD |
PMID:22155353 |
|
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
multiple interactions increases secretion |
EXP |
[Gold co-treated with Silicon Dioxide] results in increased secretion of CCL5 protein Gold results in increased secretion of CCL5 protein |
CTD |
PMID:22155353 |
|
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
|
|
G |
Ccl7 |
C-C motif chemokine ligand 7 |
multiple interactions increases secretion |
EXP |
[Gold co-treated with Silicon Dioxide] results in increased secretion of CCL7 protein Gold results in increased secretion of CCL7 protein |
CTD |
PMID:22155353 |
|
NCBI chr11:81,936,538...81,938,351
Ensembl chr11:81,936,538...81,938,351
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions |
ISO |
[Quercetin analog co-treated with Gold analog] results in decreased expression of CCND1 protein |
CTD |
PMID:27470402 |
|
NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
|
|
G |
Cct5 |
chaperonin containing TCP1 subunit 5 |
decreases expression |
EXP |
Gold analog results in decreased expression of CCT5 protein |
CTD |
PMID:24780912 |
|
NCBI chr15:31,590,946...31,601,992
Ensembl chr15:31,590,946...31,601,950
|
|
G |
Cd19 |
CD19 antigen |
increases expression |
ISO |
Gold analog results in increased expression of CD19 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 7:126,007,620...126,016,401
Ensembl chr 7:126,007,622...126,014,061
|
|
G |
Cd36 |
CD36 molecule |
decreases expression |
ISO |
Gold analog results in decreased expression of CD36 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 5:17,986,680...18,093,828
Ensembl chr 5:17,986,688...18,093,799
|
|
G |
Cd40 |
CD40 antigen |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of CD40 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
|
|
G |
Cd86 |
CD86 antigen |
decreases expression |
ISO |
Gold analog results in decreased expression of CD86 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr16:36,389,318...36,486,439
Ensembl chr16:36,424,231...36,486,443
|
|
G |
Cda |
cytidine deaminase |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of CDA mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 4:138,065,839...138,095,623
Ensembl chr 4:138,065,735...138,095,303
|
|
G |
Cdk1 |
cyclin dependent kinase 1 |
decreases expression increases expression |
ISO |
Gold results in decreased expression of CDK1 mRNA Gold results in increased expression of CDK1 mRNA |
CTD |
PMID:25523186 PMID:29705079 |
|
NCBI chr10:69,170,976...69,188,742
Ensembl chr10:69,170,976...69,188,768
|
|
G |
Cdk7 |
cyclin dependent kinase 7 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of CDK7 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr13:100,833,532...100,867,454
Ensembl chr13:100,839,139...100,867,447
|
|
G |
Cdkn1b |
cyclin dependent kinase inhibitor 1B |
multiple interactions |
ISO |
[Gold binds to Dimethyldithiocarbamate] which results in increased expression of CDKN1B protein |
CTD |
PMID:17079469 |
|
NCBI chr 6:134,897,364...134,902,488
Ensembl chr 6:134,897,364...134,902,476
|
|
G |
Cdkn2aip |
CDKN2A interacting protein |
decreases expression |
ISO |
Gold results in decreased expression of CDKN2AIP mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:48,162,379...48,166,966
Ensembl chr 8:48,162,379...48,166,967
|
|
G |
Cgrrf1 |
cell growth regulator with ring finger domain 1 |
decreases expression |
ISO |
Gold results in decreased expression of CGRRF1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr14:47,069,591...47,091,655
Ensembl chr14:47,069,582...47,091,650
|
|
G |
Chek1 |
checkpoint kinase 1 |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of CHEK1 mRNA Gold analog results in decreased expression of CHEK1 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr 9:36,619,935...36,637,897
Ensembl chr 9:36,619,778...36,638,361
|
|
G |
Chek2 |
checkpoint kinase 2 |
decreases expression |
ISO |
Gold analog results in decreased expression of CHEK2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 5:110,987,668...111,022,006
Ensembl chr 5:110,987,845...111,022,011
|
|
G |
Chordc1 |
cysteine and histidine rich domain containing 1 |
decreases expression |
ISO |
Gold results in decreased expression of CHORDC1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 9:18,203,563...18,225,296
Ensembl chr 9:18,203,421...18,228,738
|
|
G |
Cisd1 |
CDGSH iron sulfur domain 1 |
decreases expression |
ISO |
Gold results in decreased expression of CISD1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr10:71,166,324...71,180,679
Ensembl chr10:71,166,310...71,180,784
|
|
G |
Cldn12 |
claudin 12 |
decreases expression |
ISO |
Gold results in decreased expression of CLDN12 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 5:5,555,109...5,564,953
Ensembl chr 5:5,539,537...5,564,958
|
|
G |
Cnbp |
cellular nucleic acid binding protein |
decreases expression |
ISO |
Gold results in decreased expression of CNBP mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 6:87,819,597...87,828,088
Ensembl chr 6:87,819,597...87,828,088
|
|
G |
Cnot7 |
CCR4-NOT transcription complex, subunit 7 |
decreases expression |
ISO |
Gold results in decreased expression of CNOT7 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:40,945,579...40,968,888
Ensembl chr 8:40,945,581...40,968,888
|
|
G |
Col1a1 |
collagen, type I, alpha 1 |
increases expression |
EXP |
Gold analog results in increased expression of COL1A1 protein |
CTD |
PMID:24780912 |
|
NCBI chr11:94,827,050...94,843,868
Ensembl chr11:94,827,050...94,843,868
|
|
G |
Col1a2 |
collagen, type I, alpha 2 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of COL1A2 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 6:4,505,618...4,541,543
Ensembl chr 6:4,504,814...4,541,544
|
|
G |
Col3a1 |
collagen, type III, alpha 1 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of COL3A1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 1:45,350,698...45,388,866
Ensembl chr 1:45,350,698...45,388,866
|
|
G |
Commd8 |
COMM domain containing 8 |
decreases expression |
ISO |
Gold results in decreased expression of COMMD8 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 5:72,313,919...72,325,532
Ensembl chr 5:72,313,918...72,325,532
|
|
G |
Cox11 |
cytochrome c oxidase assembly protein 11, copper chaperone |
decreases expression |
ISO |
Gold results in decreased expression of COX11 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr11:90,529,010...90,536,803
Ensembl chr11:90,528,999...90,535,757
|
|
G |
Cox17 |
cytochrome c oxidase assembly protein 17, copper chaperone |
decreases expression |
ISO |
Gold results in decreased expression of COX17 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr16:38,167,332...38,173,125
Ensembl chr16:38,167,353...38,182,659
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of CPT1A mRNA |
CTD |
PMID:28433809 |
|
NCBI chr19:3,372,328...3,435,735
Ensembl chr19:3,372,334...3,435,733
|
|
G |
Cpt2 |
carnitine palmitoyltransferase 2 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of CPT2 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 4:107,761,179...107,780,786
Ensembl chr 4:107,761,178...107,780,807
|
|
G |
Crot |
carnitine O-octanoyltransferase |
decreases expression |
ISO |
Gold analog results in decreased expression of CROT mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 5:9,016,033...9,047,926
Ensembl chr 5:9,016,033...9,047,324
|
|
G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
multiple interactions increases secretion |
EXP |
[Gold co-treated with Silicon Dioxide] results in increased secretion of CSF2 protein Gold results in increased secretion of CSF2 protein |
CTD |
PMID:22155353 |
|
NCBI chr11:54,138,096...54,140,725
Ensembl chr11:54,138,097...54,140,493
|
|
G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
increases secretion multiple interactions |
EXP |
Gold results in increased secretion of CSF3 protein [Gold co-treated with Silicon Dioxide] results in increased secretion of CSF3 protein |
CTD |
PMID:22155353 |
|
NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455
|
|
G |
Ctcf |
CCCTC-binding factor |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of CTCF mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 8:106,351,135...106,409,554
Ensembl chr 8:106,363,200...106,409,554
|
|
G |
Cux1 |
cut-like homeobox 1 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of CUX1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 5:136,276,989...136,596,429
Ensembl chr 5:136,276,989...136,596,344
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
increases secretion multiple interactions |
EXP |
Gold results in increased secretion of CXCL10 protein [Gold co-treated with Silicon Dioxide] results in increased secretion of CXCL10 protein |
CTD |
PMID:22155353 |
|
NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
multiple interactions increases secretion |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of CXCL2 mRNA; [Gold co-treated with Silicon Dioxide] results in increased secretion of CXCL2 protein Gold results in increased secretion of CXCL2 protein |
CTD |
PMID:19695318 PMID:22155353 |
|
NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of CXCL1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 5:90,933,960...90,935,952
Ensembl chr 5:90,933,962...90,937,459
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions |
ISO |
[[Gold results in decreased abundance of Glutathione] which results in increased abundance of Hydrogen Peroxide] which affects the localization of CYCS protein |
CTD |
PMID:21621595 |
|
NCBI chr 6:50,539,543...50,543,549
Ensembl chr 6:50,539,543...50,543,518
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases activity decreases expression multiple interactions |
EXP ISO |
Gold analog results in increased activity of CYP1A1 protein Gold analog results in decreased expression of CYP1A1 mRNA [Polyethyleneimine binds to Gold] which results in decreased expression of CYP1A1 mRNA |
CTD |
PMID:20193702 PMID:28433809 PMID:36057382 |
|
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
|
|
G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
increases expression |
ISO |
Gold results in increased expression of CYP24A1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 2:170,324,877...170,339,065
Ensembl chr 2:170,324,628...170,339,065
|
|
G |
Cyp2d22 |
cytochrome P450, family 2, subfamily d, polypeptide 22 |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of CYP2D6 mRNA Gold analog results in decreased expression of CYP2D6 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr15:82,254,728...82,264,461
Ensembl chr15:82,254,728...82,264,461
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
decreases expression |
ISO |
Gold analog results in decreased expression of CYP2E1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
|
|
G |
Cyp3a11 |
cytochrome P450, family 3, subfamily a, polypeptide 11 |
increases expression |
EXP |
Gold analog results in increased expression of CYP3A11 mRNA |
CTD |
PMID:22486372 |
|
NCBI chr 5:145,791,417...145,816,664
Ensembl chr 5:145,791,236...145,816,774
|
|
G |
Cyp7a1 |
cytochrome P450, family 7, subfamily a, polypeptide 1 |
increases expression |
ISO |
Gold analog results in increased expression of CYP7A1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 4:6,265,612...6,275,632
Ensembl chr 4:6,265,612...6,275,633
|
|
G |
Cyth1 |
cytohesin 1 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of CYTH1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr11:118,054,996...118,139,452
Ensembl chr11:118,022,845...118,139,386
|
|
G |
Dab2 |
disabled 2, mitogen-responsive phosphoprotein |
increases expression |
ISO |
Gold results in increased expression of DAB2 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr15:6,329,269...6,470,196
Ensembl chr15:6,329,269...6,470,193
|
|
G |
Dcp2 |
decapping mRNA 2 |
decreases expression |
ISO |
Gold results in decreased expression of DCP2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr18:44,513,567...44,558,036
Ensembl chr18:44,513,569...44,558,036
|
|
G |
Ddc |
dopa decarboxylase |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of DDC mRNA |
CTD |
PMID:19695318 |
|
NCBI chr11:11,764,101...11,848,144
Ensembl chr11:11,764,101...11,848,144
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in increased expression of DDIT3 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157 Ensembl chr10:127,126,643...127,132,157
|
|
G |
Ddit4 |
DNA-damage-inducible transcript 4 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of DDIT4 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr10:59,785,497...59,787,592
Ensembl chr10:59,785,491...59,787,656
|
|
G |
Defb1 |
defensin beta 1 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of DEFB1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 8:22,266,571...22,285,201
Ensembl chr 8:22,266,615...22,285,201
|
|
G |
Dhcr24 |
24-dehydrocholesterol reductase |
multiple interactions decreases expression |
EXP ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of DHCR24 mRNA Gold analog results in decreased expression of DHCR24 mRNA [Polyethyleneimine binds to Gold] which results in decreased expression of DHCR24 mRNA |
CTD |
PMID:19695318 PMID:28433809 PMID:36057382 |
|
NCBI chr 4:106,418,279...106,446,310
Ensembl chr 4:106,418,235...106,446,310
|
|
G |
Dld |
dihydrolipoamide dehydrogenase |
decreases expression |
ISO |
Gold analog results in decreased expression of DLD mRNA |
CTD |
PMID:36057382 |
|
NCBI chr12:31,381,561...31,401,470
Ensembl chr12:31,381,276...31,401,452
|
|
G |
Dnah14 |
dynein, axonemal, heavy chain 14 |
decreases expression |
ISO |
Gold results in decreased expression of DNAH14 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:181,404,158...181,642,306
Ensembl chr 1:181,404,124...181,643,339
|
|
G |
Dnaja3 |
DnaJ heat shock protein family (Hsp40) member A3 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in increased expression of DNAJA3 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr16:4,501,934...4,525,559
Ensembl chr16:4,457,853...4,525,559
|
|
G |
Dnajb14 |
DnaJ heat shock protein family (Hsp40) member B14 |
decreases expression |
ISO |
Gold results in decreased expression of DNAJB14 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:137,572,801...137,619,350
Ensembl chr 3:137,573,436...137,622,318
|
|
G |
Dnajb6 |
DnaJ heat shock protein family (Hsp40) member B6 |
decreases expression |
ISO |
Gold results in decreased expression of DNAJB6 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 5:29,940,896...29,991,476
Ensembl chr 5:29,940,686...30,023,132
|
|
G |
Dnajb9 |
DnaJ heat shock protein family (Hsp40) member B9 |
decreases expression |
ISO |
Gold results in decreased expression of DNAJB9 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr12:44,252,680...44,256,851
Ensembl chr12:44,252,342...44,257,109
|
|
G |
Dnajc10 |
DnaJ heat shock protein family (Hsp40) member C10 |
decreases expression |
ISO |
Gold results in decreased expression of DNAJC10 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:80,145,790...80,184,399
Ensembl chr 2:80,145,810...80,184,387
|
|
G |
Dnajc19 |
DnaJ heat shock protein family (Hsp40) member C19 |
decreases expression |
ISO |
Gold results in decreased expression of DNAJC19 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:34,111,429...34,135,503
Ensembl chr 3:34,110,169...34,135,470
|
|
G |
Dnajc21 |
DnaJ heat shock protein family (Hsp40) member C21 |
decreases expression |
ISO |
Gold results in decreased expression of DNAJC21 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr15:10,446,849...10,470,685
Ensembl chr15:10,446,842...10,470,602
|
|
G |
Dnajc5 |
DnaJ heat shock protein family (Hsp40) member C5 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of DNAJC5 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 2:181,162,141...181,194,679
Ensembl chr 2:181,162,278...181,196,926
|
|
G |
Dpysl4 |
dihydropyrimidinase-like 4 |
increases expression |
ISO |
Gold analog results in increased expression of DPYSL4 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 7:138,665,917...138,681,711
Ensembl chr 7:138,665,917...138,682,620
|
|
G |
Drd3 |
dopamine receptor D3 |
multiple interactions |
ISO |
Gold inhibits the reaction [3-N-methylspiperone binds to DRD3 protein] |
CTD |
PMID:10215675 |
|
NCBI chr16:43,574,285...43,646,353
Ensembl chr16:43,574,389...43,643,295
|
|
G |
Drd4 |
dopamine receptor D4 |
multiple interactions |
ISO |
Gold inhibits the reaction [3-N-methylspiperone binds to DRD4 protein] |
CTD |
PMID:10215675 |
|
NCBI chr 7:140,871,931...140,874,868
Ensembl chr 7:140,871,919...140,876,377
|
|
G |
Dsc2 |
desmocollin 2 |
increases expression |
ISO |
Gold results in increased expression of DSC2 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr18:20,163,690...20,192,611
Ensembl chr18:20,163,690...20,192,611
|
|
G |
Dsg2 |
desmoglein 2 |
increases expression |
ISO |
Gold results in increased expression of DSG2 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr18:20,691,247...20,737,583
Ensembl chr18:20,691,131...20,737,578
|
|
G |
Duox1 |
dual oxidase 1 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of DUOX1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 2:122,143,525...122,178,454
Ensembl chr 2:122,146,153...122,178,453
|
|
G |
Duox2 |
dual oxidase 2 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of DUOX2 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 2:122,109,727...122,129,221
Ensembl chr 2:122,109,728...122,128,930
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of DUSP1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr17:26,724,565...26,727,446
Ensembl chr17:26,724,564...26,781,102
|
|
G |
Dusp11 |
dual specificity phosphatase 11 (RNA/RNP complex 1-interacting) |
decreases expression |
ISO |
Gold results in decreased expression of DUSP11 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 6:85,919,250...85,938,950
Ensembl chr 6:85,919,250...85,938,649
|
|
G |
Dut |
deoxyuridine triphosphatase |
decreases expression |
ISO |
Gold results in decreased expression of DUT mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:125,089,168...125,100,969
Ensembl chr 2:125,089,110...125,100,528
|
|
G |
Dzip3 |
DAZ interacting protein 3, zinc finger |
decreases expression |
ISO |
Gold results in decreased expression of DZIP3 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr16:48,744,591...48,814,505
Ensembl chr16:48,744,595...48,814,528
|
|
G |
Edem3 |
ER degradation enhancer, mannosidase alpha-like 3 |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of EDEM3 mRNA Gold analog results in decreased expression of EDEM3 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr 1:151,631,099...151,698,079
Ensembl chr 1:151,631,122...151,697,802
|
|
G |
Eea1 |
early endosome antigen 1 |
decreases expression |
ISO |
Gold results in decreased expression of EEA1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr10:95,776,525...95,881,380
Ensembl chr10:95,776,512...95,881,380
|
|
G |
Eef1d |
eukaryotic translation elongation factor 1 delta |
decreases expression |
EXP |
Gold analog results in decreased expression of EEF1D protein |
CTD |
PMID:24780912 |
|
NCBI chr15:75,766,643...75,781,425
Ensembl chr15:75,766,054...75,781,405
|
|
G |
Eef2 |
eukaryotic translation elongation factor 2 |
decreases expression |
EXP |
Gold analog results in decreased expression of EEF2 protein |
CTD |
PMID:24780912 |
|
NCBI chr10:81,012,465...81,018,343
Ensembl chr10:81,012,465...81,018,332
|
|
G |
Egf |
epidermal growth factor |
multiple interactions |
ISO |
[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased acetylation of and results in increased stability of EP300 protein]; [Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 mRNA]; [Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 protein]; [Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]; [Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased phosphorylation of JUN protein]; [Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased phosphorylation of RELA protein]; EP300 protein inhibits the reaction [[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 protein]]; MAP2K1 inhibits the reaction [[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 protein]]; MAP2K1 inhibits the reaction [[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased phosphorylation of JUN protein]] |
CTD |
PMID:27634460 |
|
NCBI chr 3:129,471,223...129,548,971
Ensembl chr 3:129,471,214...129,548,965
|
|
G |
Egfr |
epidermal growth factor receptor |
multiple interactions |
ISO |
[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein] |
CTD |
PMID:27634460 |
|
NCBI chr11:16,700,153...16,868,158
Ensembl chr11:16,702,203...16,868,158
|
|
G |
Ehhadh |
enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase |
decreases expression |
ISO |
Gold analog results in decreased expression of EHHADH mRNA |
CTD |
PMID:36057382 |
|
NCBI chr16:21,580,035...21,606,589
Ensembl chr16:21,580,037...21,606,557
|
|
G |
Eid1 |
EP300 interacting inhibitor of differentiation 1 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of EID1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 2:125,515,020...125,517,563
Ensembl chr 2:125,515,015...125,516,705
|
|
G |
Eif1ax |
eukaryotic translation initiation factor 1A, X-linked |
decreases expression |
ISO |
Gold results in decreased expression of EIF1AX mRNA |
CTD |
PMID:25523186 |
|
NCBI chr X:158,155,174...158,172,617
Ensembl chr X:158,155,174...158,172,924
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
increases phosphorylation |
ISO |
Gold analog results in increased phosphorylation of EIF2AK3 protein |
CTD |
PMID:26551149 |
|
NCBI chr 6:70,821,468...70,882,225
Ensembl chr 6:70,821,499...70,882,229
|
|
G |
Eif4a2 |
eukaryotic translation initiation factor 4A2 |
decreases expression |
ISO |
Gold results in decreased expression of EIF4A2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr16:22,924,846...22,932,882
Ensembl chr16:22,926,194...22,932,886
|
|
G |
Eif4e |
eukaryotic translation initiation factor 4E |
multiple interactions |
ISO |
[Quercetin analog co-treated with Gold analog] results in decreased expression of EIF4E protein |
CTD |
PMID:27470402 |
|
NCBI chr 3:138,231,952...138,265,457
Ensembl chr 3:138,231,940...138,265,457
|
|
G |
Eif4ebp3 |
eukaryotic translation initiation factor 4E binding protein 3 |
multiple interactions |
ISO |
[Quercetin analog co-treated with Gold analog] results in increased expression of EIF4EBP3 protein |
CTD |
PMID:27470402 |
|
NCBI chr18:36,797,113...36,799,377
Ensembl chr18:36,797,113...36,798,970
|
|
G |
Eif5b |
eukaryotic translation initiation factor 5B |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of EIF5B mRNA Gold analog results in decreased expression of EIF5B mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr 1:38,037,091...38,094,660
Ensembl chr 1:38,037,091...38,094,660
|
|
G |
Eno1 |
enolase 1, alpha non-neuron |
multiple interactions |
EXP |
Gold analog results in decreased expression of and results in increased phosphorylation of ENO1 protein |
CTD |
PMID:24780912 |
|
NCBI chr 4:150,321,165...150,333,336
Ensembl chr 4:150,321,178...150,333,336 Ensembl chr18:150,321,178...150,333,336
|
|
G |
Ep300 |
E1A binding protein p300 |
multiple interactions |
ISO |
[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased acetylation of and results in increased stability of EP300 protein]; [Polyethyleneimine binds to Gold] which results in decreased expression of EP300 mRNA; EP300 protein inhibits the reaction [[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 protein]] |
CTD |
PMID:27634460 PMID:28433809 |
|
NCBI chr15:81,470,329...81,536,273
Ensembl chr15:81,469,552...81,536,278
|
|
G |
Epgn |
epithelial mitogen |
increases expression |
ISO |
Gold results in increased expression of EPGN mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 5:91,175,376...91,183,071
Ensembl chr 5:91,175,323...91,183,074
|
|
G |
Epha1 |
Eph receptor A1 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of EPHA1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 6:42,335,421...42,350,249
Ensembl chr 6:42,335,421...42,350,202
|
|
G |
Ephx1 |
epoxide hydrolase 1, microsomal |
increases expression |
ISO |
Gold analog results in increased expression of EPHX1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 1:180,817,121...180,845,134
Ensembl chr 1:180,803,775...180,848,469
|
|
G |
Ercc2 |
excision repair cross-complementing rodent repair deficiency, complementation group 2 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of ERCC2 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 7:19,115,942...19,129,619
Ensembl chr 7:19,115,935...19,129,619
|
|
G |
Ercc6 |
excision repair cross-complementing rodent repair deficiency, complementation group 6 |
decreases expression |
ISO |
Gold analog results in decreased expression of ERCC6 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr14:32,235,248...32,302,947
Ensembl chr14:32,235,478...32,302,947
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signalling 1 |
increases phosphorylation |
ISO |
Gold analog results in increased phosphorylation of ERN1 protein |
CTD |
PMID:26551149 |
|
NCBI chr11:106,285,474...106,378,701
Ensembl chr11:106,285,476...106,378,678
|
|
G |
Ern2 |
endoplasmic reticulum to nucleus signalling 2 |
increases expression |
ISO |
Gold analog results in increased expression of ERN2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 7:121,769,116...121,785,454
Ensembl chr 7:121,769,116...121,785,430
|
|
G |
Ero1a |
endoplasmic reticulum oxidoreductase 1 alpha |
increases expression |
ISO |
Gold results in increased expression of ERO1A mRNA |
CTD |
PMID:29705079 |
|
NCBI chr14:45,520,544...45,556,029
Ensembl chr14:45,520,544...45,556,228
|
|
G |
Esco2 |
establishment of sister chromatid cohesion N-acetyltransferase 2 |
decreases expression |
ISO |
Gold results in decreased expression of ESCO2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr14:66,056,476...66,071,418
Ensembl chr14:66,056,487...66,071,443
|
|
G |
Esr1 |
estrogen receptor 1 (alpha) |
decreases expression |
ISO |
Gold analog results in decreased expression of ESR1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
|
|
G |
EU599041 |
expressed sequence EU599041 |
decreases expression |
ISO |
Gold results in decreased expression of ZNF124 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 7:42,863,463...42,876,676
Ensembl chr 7:42,863,422...42,901,968
|
|
G |
Evi5 |
ecotropic viral integration site 5 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of EVI5 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 5:107,892,661...108,022,973
Ensembl chr 5:107,892,661...108,022,973
|
|
G |
Evx1 |
even-skipped homeobox 1 |
increases expression |
ISO |
Gold results in increased expression of EVX1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 6:52,290,483...52,295,374
Ensembl chr 6:52,290,483...52,295,363
|
|
G |
Fancl |
Fanconi anemia, complementation group L |
decreases expression |
ISO |
Gold results in decreased expression of FANCL mRNA |
CTD |
PMID:25523186 |
|
NCBI chr11:26,337,084...26,421,883
Ensembl chr11:26,336,135...26,421,876
|
|
G |
Fas |
Fas cell surface death receptor |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of FAS mRNA Gold analog results in decreased expression of FAS mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
|
|
G |
Fasn |
fatty acid synthase |
decreases expression |
ISO |
Gold analog results in decreased expression of FASN mRNA |
CTD |
PMID:36057382 |
|
NCBI chr11:120,696,784...120,715,992
Ensembl chr11:120,696,672...120,715,373
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of FGF1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr18:38,971,725...39,062,532
Ensembl chr18:38,971,726...39,062,525
|
|
G |
Fh1 |
fumarate hydratase 1 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in increased expression of FH mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 1:175,428,944...175,453,201
Ensembl chr 1:175,427,940...175,453,201
|
|
G |
Fkbp9 |
FK506 binding protein 9 |
increases phosphorylation decreases expression |
EXP |
Gold analog results in increased phosphorylation of FKBP9 protein Gold analog results in decreased expression of FKBP9 protein |
CTD |
PMID:24780912 |
|
NCBI chr 6:56,809,044...56,856,345
Ensembl chr 6:56,809,044...56,856,343
|
|
G |
Fmo5 |
flavin containing monooxygenase 5 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of FMO5 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 3:97,517,248...97,562,603
Ensembl chr 3:97,536,120...97,562,598
|
|
G |
Fos |
FBJ osteosarcoma oncogene |
multiple interactions increases expression |
EXP |
[Gold co-treated with Silicon Dioxide] results in increased expression of FOS mRNA Gold results in increased expression of FOS mRNA |
CTD |
PMID:22155353 |
|
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
|
|
G |
Fth1 |
ferritin heavy polypeptide 1 |
increases expression |
ISO |
Gold results in increased expression of FTH1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr19:9,957,964...9,962,475
Ensembl chr19:9,957,962...9,962,462
|
|
G |
Fyb1 |
FYN binding protein 1 |
increases expression |
ISO |
Gold results in increased expression of FYB1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr15:6,552,280...6,695,089
Ensembl chr15:6,552,334...6,692,794
|
|
G |
Fzd4 |
frizzled class receptor 4 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of FZD4 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 7:89,053,574...89,062,341
Ensembl chr 7:89,053,563...89,062,342
|
|
G |
G2e3 |
G2/M-phase specific E3 ubiquitin ligase |
decreases expression |
ISO |
Gold results in decreased expression of G2E3 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr12:51,395,013...51,423,769
Ensembl chr12:51,394,844...51,423,769
|
|
G |
Galnt1 |
polypeptide N-acetylgalactosaminyltransferase 1 |
decreases expression |
ISO |
Gold results in decreased expression of GALNT1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr18:24,338,401...24,419,873
Ensembl chr18:24,338,401...24,419,875
|
|
G |
Galnt5 |
polypeptide N-acetylgalactosaminyltransferase 5 |
decreases expression |
ISO |
Gold analog results in decreased expression of GALNT5 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 2:57,887,832...57,931,039
Ensembl chr 2:57,887,896...57,935,872
|
|
G |
Ganc |
glucosidase, alpha; neutral C |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of GANC mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 2:120,234,377...120,291,347
Ensembl chr 2:120,234,377...120,292,181
|
|
G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
decreases expression |
EXP |
Gold analog results in decreased expression of GAPDH protein |
CTD |
PMID:24780912 |
|
NCBI chr 6:125,138,812...125,143,450
Ensembl chr 6:125,138,678...125,143,430
|
|
G |
Gca |
grancalcin |
decreases expression |
ISO |
Gold results in decreased expression of GCA mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:62,494,671...62,524,453
Ensembl chr 2:62,494,629...62,524,453
|
|
G |
Gcdh |
glutaryl-Coenzyme A dehydrogenase |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of GCDH mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 8:85,613,016...85,629,378
Ensembl chr 8:85,613,022...85,620,550
|
|
G |
Gmps |
guanine monophosphate synthetase |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of GMPS mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 3:63,871,054...63,928,975
Ensembl chr 3:63,883,527...63,930,000
|
|
G |
Gng10 |
guanine nucleotide binding protein (G protein), gamma 10 |
decreases expression |
ISO |
Gold results in decreased expression of GNG10 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:59,035,156...59,041,899
Ensembl chr 4:59,035,088...59,041,903
|
|
G |
Got2 |
glutamatic-oxaloacetic transaminase 2, mitochondrial |
decreases expression |
EXP |
Gold analog results in decreased expression of GOT2 protein |
CTD |
PMID:24780912 |
|
NCBI chr 8:96,590,761...96,615,029
Ensembl chr 8:96,590,762...96,615,175
|
|
G |
Gpr182 |
G protein-coupled receptor 182 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of GPR182 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr10:127,585,471...127,587,667
Ensembl chr10:127,583,145...127,587,601
|
|
G |
Gpt |
glutamic pyruvic transaminase, soluble |
multiple interactions decreases expression |
EXP ISO |
[Gold binds to NKCT1 protein, Naja kaouthia] inhibits the reaction [Diethylnitrosamine results in increased activity of GPT protein]; [Gold binds to NKCT1 protein, Naja kaouthia] inhibits the reaction [Diethylnitrosamine results in increased expression of GPT protein] Gold analog results in decreased expression of GPT mRNA [Polyethyleneimine binds to Gold] which results in decreased expression of GPT mRNA |
CTD |
PMID:27836789 PMID:28433809 PMID:36057382 |
|
NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
increases expression |
ISO |
Gold analog results in increased expression of GPX2 mRNA; Gold results in increased expression of GPX2 mRNA |
CTD |
PMID:25523186 PMID:36057382 |
|
NCBI chr12:76,839,109...76,842,328
Ensembl chr12:76,839,107...76,842,273
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
increases expression |
ISO |
Gold analog results in increased expression of GPX3 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr11:54,793,680...54,801,213
Ensembl chr11:54,793,279...54,801,203
|
|
G |
Gsn |
gelsolin |
decreases expression increases degradation |
EXP ISO |
Gold analog results in decreased expression of GSN protein Gold analog results in increased degradation of GSN protein |
CTD |
PMID:24780912 PMID:26551149 |
|
NCBI chr 2:35,146,371...35,197,914
Ensembl chr 2:35,146,392...35,197,904
|
|
G |
Gstm4 |
glutathione S-transferase, mu 4 |
multiple interactions increases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of GSTM4 mRNA Gold analog results in increased expression of GSTM4 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr 3:107,937,887...107,952,495
Ensembl chr 3:107,947,724...107,952,210
|
|
G |
H2-Eb1 |
histocompatibility 2, class II antigen E beta |
increases expression |
ISO |
Gold analog results in increased expression of HLA-DRB1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr17:34,524,841...34,535,648
Ensembl chr17:34,524,841...34,535,648
|
|
G |
H2-M2 |
histocompatibility 2, M region locus 2 |
affects response to substance |
ISO |
HLA-B gene polymorphism affects the susceptibility to Gold |
CTD |
PMID:3084782 |
|
NCBI chr17:37,791,742...37,794,445
Ensembl chr17:37,791,742...37,794,443
|
|
G |
Haao |
3-hydroxyanthranilate 3,4-dioxygenase |
increases expression |
ISO |
Gold analog results in increased expression of HAAO mRNA |
CTD |
PMID:36057382 |
|
NCBI chr17:84,138,777...84,157,589
Ensembl chr17:84,138,585...84,155,392
|
|
G |
Hat1 |
histone aminotransferase 1 |
decreases expression |
ISO |
Gold results in decreased expression of HAT1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:71,219,604...71,271,966
Ensembl chr 2:71,219,302...71,271,966
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
multiple interactions |
ISO |
[Polyethylene Glycols binds to Gold] which results in increased expression of HAVCR1 protein; [Polyethyleneimine binds to Gold] which results in increased expression of HAVCR1 protein; [Thioctic Acid binds to Gold] which results in increased expression of HAVCR1 protein |
CTD |
PMID:28433809 |
|
NCBI chr11:46,630,644...46,670,405
Ensembl chr11:46,625,907...46,670,405
|
|
G |
Hexb |
hexosaminidase B |
multiple interactions |
ISO |
[gold chloride results in increased abundance of Gold] which results in increased export of HEXB protein; [gold tetrachloride, acid results in increased abundance of Gold] which results in increased export of HEXB protein |
CTD |
PMID:21376117 |
|
NCBI chr13:97,312,839...97,334,865
Ensembl chr13:97,312,839...97,334,865
|
|
G |
Hmgb2 |
high mobility group box 2 |
decreases expression |
ISO |
Gold results in decreased expression of HMGB2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:57,964,877...57,969,033
Ensembl chr 8:57,964,941...57,969,033
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
ISO |
Gold results in increased expression of HMOX1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
|
|
G |
Hoxa3 |
homeobox A3 |
decreases expression |
ISO |
Gold analog results in decreased expression of HOXA3 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 6:52,146,039...52,190,316
Ensembl chr 6:52,146,042...52,190,316
|
|
G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
decreases expression |
ISO |
Gold results in decreased expression of HPRT1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr X:52,076,955...52,110,537
Ensembl chr X:52,077,014...52,110,536
|
|
G |
Hpx |
hemopexin |
decreases expression |
ISO |
Gold analog results in decreased expression of HPX mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 7:105,240,818...105,249,323
Ensembl chr 7:105,240,820...105,249,344
|
|
G |
Hsbp1 |
heat shock factor binding protein 1 |
decreases expression |
ISO |
Gold results in decreased expression of HSBP1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:120,071,277...120,075,668
Ensembl chr 8:120,071,227...120,075,661
|
|
G |
Hsf1 |
heat shock factor 1 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of HSF1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr15:76,361,562...76,385,355
Ensembl chr15:76,361,622...76,386,113
|
|
G |
Hsp90ab1 |
heat shock protein 90 alpha (cytosolic), class B member 1 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of HSP90AB1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr17:45,878,704...45,884,187
Ensembl chr17:45,878,701...45,884,197
|
|
G |
Hspa13 |
heat shock protein 70 family, member 13 |
decreases expression |
ISO |
Gold results in decreased expression of HSPA13 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr16:75,552,078...75,564,575
Ensembl chr16:75,542,319...75,563,992
|
|
G |
Hspa1a |
heat shock protein 1A |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of HSPA1A mRNA |
CTD |
PMID:28433809 |
|
NCBI chr17:35,188,335...35,191,132
Ensembl chr17:35,188,166...35,191,132
|
|
G |
Hspa1b |
heat shock protein 1B |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of HSPA1B mRNA |
CTD |
PMID:28433809 |
|
NCBI chr17:35,175,405...35,178,214
Ensembl chr17:35,175,412...35,178,214
|
|
G |
Hspa2 |
heat shock protein 2 |
decreases expression |
ISO |
Gold analog results in decreased expression of HSPA2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr12:76,450,688...76,453,712
Ensembl chr12:76,450,950...76,453,712
|
|
G |
Hspa4 |
heat shock protein 4 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of HSPA4 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr11:53,150,641...53,191,306
Ensembl chr11:53,150,641...53,191,284
|
|
G |
Hspa8 |
heat shock protein 8 |
increases expression |
EXP |
Gold analog results in increased expression of HSPA8 protein |
CTD |
PMID:24780912 |
|
NCBI chr 9:40,712,572...40,716,498
Ensembl chr 9:40,712,280...40,721,383
|
|
G |
Hspa9 |
heat shock protein 9 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of HSPA9 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr18:35,070,467...35,087,404
Ensembl chr18:35,070,467...35,087,410
|
|
G |
Hspb1 |
heat shock protein 1 |
multiple interactions |
EXP ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of HSPB1 mRNA [Polyethyleneimine binds to Gold] which results in decreased expression of HSPB1 mRNA |
CTD |
PMID:19695318 PMID:28433809 |
|
NCBI chr 5:135,916,773...135,918,417
Ensembl chr 5:135,916,773...135,918,417
|
|
G |
Hspd1 |
heat shock protein 1 (chaperonin) |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in increased expression of HSPD1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 1:55,116,992...55,127,402
Ensembl chr 1:55,116,994...55,127,402
|
|
G |
Htatip2 |
HIV-1 Tat interactive protein 2 |
increases expression |
ISO |
Gold results in increased expression of HTATIP2 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 7:49,408,761...49,423,748
Ensembl chr 7:49,408,863...49,423,723
|
|
G |
Htatsf1 |
HIV TAT specific factor 1 |
decreases expression |
ISO |
Gold results in decreased expression of HTATSF1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr X:56,098,930...56,112,543
Ensembl chr X:56,098,943...56,112,543
|
|
G |
Htra4 |
HtrA serine peptidase 4 |
decreases expression |
ISO |
Gold analog results in decreased expression of HTRA4 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 8:25,514,944...25,529,160
Ensembl chr 8:25,514,945...25,528,978
|
|
G |
Hyou1 |
hypoxia up-regulated 1 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of HYOU1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 9:44,290,840...44,303,662
Ensembl chr 9:44,290,787...44,303,666
|
|
G |
Idh1 |
isocitrate dehydrogenase 1 (NADP+), soluble |
multiple interactions |
EXP |
Gold analog results in decreased expression of and results in increased phosphorylation of IDH1 protein |
CTD |
PMID:24780912 |
|
NCBI chr 1:65,197,775...65,225,638
Ensembl chr 1:65,197,775...65,225,659
|
|
G |
Idh3g |
isocitrate dehydrogenase 3 (NAD+), gamma |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in increased expression of IDH3G mRNA |
CTD |
PMID:28433809 |
|
NCBI chr X:72,822,569...72,830,471
Ensembl chr X:72,822,569...72,830,503
|
|
G |
Ifngr1 |
interferon gamma receptor 1 |
increases expression |
ISO |
Gold results in increased expression of IFNGR1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr10:19,467,697...19,485,977
Ensembl chr10:19,467,697...19,485,977
|
|
G |
Igf1 |
insulin-like growth factor 1 |
multiple interactions |
ISO |
Gold inhibits the reaction [IGF1 protein binds to IGF1R protein] |
CTD |
PMID:9648927 |
|
NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904
|
|
G |
Igf1r |
insulin-like growth factor I receptor |
multiple interactions |
ISO |
Gold inhibits the reaction [IGF1 protein binds to IGF1R protein]; Gold inhibits the reaction [IGF2 protein binds to IGF1R protein] |
CTD |
PMID:9648927 |
|
NCBI chr 7:67,601,486...67,883,416
Ensembl chr 7:67,602,575...67,883,416
|
|
G |
Igf2 |
insulin-like growth factor 2 |
multiple interactions |
ISO |
Gold inhibits the reaction [IGF2 protein binds to IGF1R protein] |
CTD |
PMID:9648927 |
|
NCBI chr 7:142,204,505...142,220,566
Ensembl chr 7:142,204,503...142,220,553
|
|
G |
Ikzf2 |
IKAROS family zinc finger 2 |
decreases expression |
ISO |
Gold results in decreased expression of IKZF2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:69,570,382...69,726,510
Ensembl chr 1:69,570,373...69,726,404
|
|
G |
Il10 |
interleukin 10 |
multiple interactions increases secretion |
EXP |
[Gold co-treated with Silicon Dioxide] results in increased secretion of IL10 protein Gold results in increased secretion of IL10 protein |
CTD |
PMID:22155353 |
|
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
|
|
G |
Il1a |
interleukin 1 alpha |
multiple interactions decreases expression increases secretion |
EXP ISO |
[Gold co-treated with Silicon Dioxide] results in increased secretion of IL1A protein Gold analog results in decreased expression of IL1A mRNA Gold results in increased secretion of IL1A protein |
CTD |
PMID:22155353 PMID:36057382 |
|
NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions decreases expression increases secretion |
EXP ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of IL1B mRNA; [Gold co-treated with Silicon Dioxide] results in increased secretion of IL1B protein Gold analog results in decreased expression of IL1B mRNA Gold results in increased secretion of IL1B protein |
CTD |
PMID:19695318 PMID:22155353 PMID:36057382 |
|
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
|
|
G |
Il4 |
interleukin 4 |
decreases expression |
ISO |
Gold analog results in decreased expression of IL4 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
|
|
G |
Il6 |
interleukin 6 |
multiple interactions increases secretion |
EXP ISO |
[Gold co-treated with Polyethylene Glycols] results in increased expression of IL6 mRNA; [Gold co-treated with Silicon Dioxide] results in increased secretion of IL6 protein [Polyethylene Glycols binds to Gold] which results in increased expression of IL6 protein; [Polyethyleneimine binds to Gold] which results in increased expression of IL6 protein; [Thioctic Acid binds to Gold] which results in increased expression of IL6 protein Gold results in increased secretion of IL6 protein |
CTD |
PMID:19695318 PMID:22155353 PMID:28433809 |
|
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
Il6ra |
interleukin 6 receptor, alpha |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of IL6RA mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 3:89,776,631...89,820,503
Ensembl chr 3:89,771,366...89,820,503
|
|
G |
Impa1 |
inositol (myo)-1(or 4)-monophosphatase 1 |
decreases expression |
ISO |
Gold results in decreased expression of IMPA1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:10,377,016...10,396,499
Ensembl chr 3:10,377,016...10,396,499
|
|
G |
Ipmk |
inositol polyphosphate multikinase |
decreases expression |
ISO |
Gold results in decreased expression of IPMK mRNA |
CTD |
PMID:25523186 |
|
NCBI chr10:71,183,574...71,221,715
Ensembl chr10:71,183,593...71,269,157
|
|
G |
Iqgap2 |
IQ motif containing GTPase activating protein 2 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of IQGAP2 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr13:95,763,685...96,028,788
Ensembl chr13:95,763,682...96,028,991
|
|
G |
Jag1 |
jagged 1 |
decreases expression |
ISO |
Gold analog results in decreased expression of JAG1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 2:136,923,371...136,958,440
Ensembl chr 2:136,923,376...136,958,564
|
|
G |
Jak2 |
Janus kinase 2 |
multiple interactions |
ISO |
[Quercetin analog co-treated with Gold analog] results in decreased phosphorylation of JAK2 protein |
CTD |
PMID:27470402 |
|
NCBI chr19:29,229,006...29,290,495
Ensembl chr19:29,229,228...29,290,480
|
|
G |
Jun |
jun proto-oncogene |
multiple interactions |
ISO |
[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased phosphorylation of JUN protein]; MAP2K1 inhibits the reaction [[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased phosphorylation of JUN protein]] |
CTD |
PMID:27634460 |
|
NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
|
|
G |
Jup |
junction plakoglobin |
decreases expression |
EXP |
Gold analog results in decreased expression of JUP protein |
CTD |
PMID:24780912 |
|
NCBI chr11:100,259,682...100,288,639
Ensembl chr11:100,259,784...100,288,589
|
|
G |
Khk |
ketohexokinase |
increases expression |
ISO |
Gold analog results in increased expression of KHK mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 5:31,078,780...31,088,592
Ensembl chr 5:31,078,775...31,088,592
|
|
G |
Kin |
Kin17 DNA and RNA binding protein |
decreases expression |
ISO |
Gold results in decreased expression of KIN mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:10,085,397...10,097,512
Ensembl chr 2:10,085,404...10,097,617
|
|
G |
Kitl |
kit ligand |
decreases expression |
ISO |
Gold results in decreased expression of KITLG mRNA |
CTD |
PMID:25523186 |
|
NCBI chr10:99,851,477...99,936,278
Ensembl chr10:99,851,492...99,936,278
|
|
G |
Krr1 |
KRR1, small subunit (SSU) processome component, homolog (yeast) |
decreases expression |
ISO |
Gold results in decreased expression of KRR1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr10:111,808,600...111,824,335
Ensembl chr10:111,808,569...111,824,337
|
|
G |
Kynu |
kynureninase |
increases expression |
ISO |
Gold results in increased expression of KYNU mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 2:43,445,270...43,572,734
Ensembl chr 2:43,445,341...43,572,734
|
|
G |
Lacc1 |
laccase domain containing 1 |
increases expression |
ISO |
Gold results in increased expression of LACC1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr14:77,261,640...77,274,344
Ensembl chr14:77,261,640...77,274,344
|
|
G |
Lactb2 |
lactamase, beta 2 |
decreases expression |
ISO |
Gold results in decreased expression of LACTB2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:13,695,069...13,730,749
Ensembl chr 1:13,693,554...13,730,770
|
|
G |
Larp1b |
La ribonucleoprotein 1B |
decreases expression |
ISO |
Gold results in decreased expression of LARP1B mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:40,904,198...40,994,642
Ensembl chr 3:40,904,263...40,994,669
|
|
G |
Lif |
leukemia inhibitory factor |
multiple interactions increases secretion |
EXP |
[Gold co-treated with Silicon Dioxide] results in increased secretion of LIF protein Gold results in increased secretion of LIF protein |
CTD |
PMID:22155353 |
|
NCBI chr11:4,207,587...4,222,514
Ensembl chr11:4,207,557...4,222,514
|
|
G |
Lig4 |
ligase IV, DNA, ATP-dependent |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which affects the expression of LIG4 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 8:10,020,020...10,027,680
Ensembl chr 8:10,019,049...10,027,686
|
|
G |
Lima1 |
LIM domain and actin binding 1 |
decreases expression |
ISO |
Gold results in decreased expression of LIMA1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr15:99,676,351...99,773,292
Ensembl chr15:99,676,351...99,773,337
|
|
G |
Lman1 |
lectin, mannose-binding, 1 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of LMAN1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr18:66,113,810...66,135,706
Ensembl chr18:66,113,809...66,155,651
|
|
G |
Lmna |
lamin A |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of LMNA mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 3:88,388,455...88,413,842
Ensembl chr 3:88,387,454...88,417,263
|
|
G |
Lmnb1 |
lamin B1 |
increases degradation |
ISO |
Gold analog results in increased degradation of LMNB1 protein |
CTD |
PMID:26551149 |
|
NCBI chr18:56,840,885...56,886,496
Ensembl chr18:56,840,885...56,886,496
|
|
G |
Lpgat1 |
lysophosphatidylglycerol acyltransferase 1 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of LPGAT1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 1:191,449,682...191,516,367
Ensembl chr 1:191,449,946...191,516,367
|
|
G |
Lratd1 |
LRAT domain containing 1 |
increases expression |
ISO |
Gold results in increased expression of LRATD1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr12:14,197,599...14,202,039
Ensembl chr12:14,196,831...14,202,055
|
|
G |
Lsm5 |
LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated |
decreases expression |
ISO |
Gold results in decreased expression of LSM5 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 6:56,678,048...56,681,684
Ensembl chr 6:56,678,048...56,681,695
|
|
G |
Lsm6 |
LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated |
decreases expression |
ISO |
Gold results in decreased expression of LSM6 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:79,531,497...79,547,781
Ensembl chr 8:79,531,494...79,547,769
|
|
G |
Lss |
lanosterol synthase |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of LSS mRNA |
CTD |
PMID:28433809 |
|
NCBI chr10:76,367,303...76,392,973
Ensembl chr10:76,367,422...76,392,972
|
|
G |
Mad2l1 |
MAD2 mitotic arrest deficient-like 1 |
decreases expression |
ISO |
Gold results in decreased expression of MAD2L1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 6:66,512,205...66,518,091
Ensembl chr 6:66,512,374...66,524,204
|
|
G |
Map1b |
microtubule-associated protein 1B |
increases expression |
ISO |
Gold results in increased expression of MAP1B mRNA |
CTD |
PMID:29705079 |
|
NCBI chr13:99,557,972...99,653,110
Ensembl chr13:99,557,954...99,653,048
|
|
G |
Map2k1 |
mitogen-activated protein kinase kinase 1 |
multiple interactions |
ISO |
MAP2K1 inhibits the reaction [[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 protein]]; MAP2K1 inhibits the reaction [[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased phosphorylation of JUN protein]] |
CTD |
PMID:27634460 |
|
NCBI chr 9:64,093,066...64,160,887
Ensembl chr 9:64,093,052...64,160,913
|
|
G |
Mbnl2 |
muscleblind like splicing factor 2 |
decreases expression |
ISO |
Gold results in decreased expression of MBNL2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr14:120,513,077...120,669,110
Ensembl chr14:120,513,081...120,669,109
|
|
G |
Mdh1b |
malate dehydrogenase 1B, NAD (soluble) |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of MDH1B mRNA Gold analog results in decreased expression of MDH1B mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr 1:63,726,732...63,769,707
Ensembl chr 1:63,737,978...63,769,477
|
|
G |
Mdm2 |
transformed mouse 3T3 cell double minute 2 |
decreases expression |
ISO |
Gold analog results in decreased expression of MDM2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr10:117,524,780...117,546,663
Ensembl chr10:117,524,780...117,546,663
|
|
G |
Mecr |
mitochondrial trans-2-enoyl-CoA reductase |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of MECR mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 4:131,570,755...131,595,097
Ensembl chr 4:131,570,781...131,595,097
|
|
G |
Mefv |
Mediterranean fever |
increases expression |
ISO |
Gold results in increased expression of MEFV mRNA |
CTD |
PMID:25523186 |
|
NCBI chr16:3,524,838...3,536,073
Ensembl chr16:3,525,082...3,535,961
|
|
G |
Metap2 |
methionine aminopeptidase 2 |
decreases expression |
ISO |
Gold analog results in decreased expression of METAP2 mRNA; Gold results in decreased expression of METAP2 mRNA |
CTD |
PMID:25523186 PMID:36057382 |
|
NCBI chr10:93,694,351...93,732,952
Ensembl chr10:93,694,351...93,732,955
|
|
G |
Mki67 |
antigen identified by monoclonal antibody Ki 67 |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in increased expression of MKI67 mRNA Gold analog results in decreased expression of MKI67 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr 7:135,291,513...135,318,286
Ensembl chr 7:135,291,513...135,318,090
|
|
G |
Mmgt1 |
membrane magnesium transporter 1 |
decreases expression |
ISO |
Gold results in decreased expression of MMGT1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr X:55,630,872...55,643,304
Ensembl chr X:55,630,872...55,643,429
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
increases expression |
ISO |
Gold results in increased expression of MMP3 mRNA |
CTD |
PMID:24022940 |
|
NCBI chr 9:7,445,845...7,455,975
Ensembl chr 9:7,445,822...7,455,975
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions |
ISO |
[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 mRNA]; [Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 protein]; EP300 protein inhibits the reaction [[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 protein]]; MAP2K1 inhibits the reaction [[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased expression of MMP9 protein]] |
CTD |
PMID:27634460 |
|
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
|
|
G |
Mnat1 |
menage a trois 1 |
decreases expression |
ISO |
Gold results in decreased expression of MNAT1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr12:73,158,957...73,320,762
Ensembl chr12:73,170,491...73,320,762
|
|
G |
Mob1b |
MOB kinase activator 1B |
decreases expression |
ISO |
Gold results in decreased expression of MOB1B mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 5:88,868,730...88,906,314
Ensembl chr 5:88,868,714...88,912,079
|
|
G |
Mob4 |
MOB family member 4, phocein |
decreases expression |
ISO |
Gold results in decreased expression of MOB4 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:55,170,404...55,194,058
Ensembl chr 1:55,170,390...55,194,058
|
|
G |
Morc3 |
microrchidia 3 |
decreases expression |
ISO |
Gold results in decreased expression of MORC3 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr16:93,629,009...93,672,964
Ensembl chr16:93,629,009...93,672,961
|
|
G |
Mrpl3 |
mitochondrial ribosomal protein L3 |
decreases expression |
ISO |
Gold results in decreased expression of MRPL3 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 9:104,930,394...104,954,665
Ensembl chr 9:104,930,438...104,957,087
|
|
G |
Mrps6 |
mitochondrial ribosomal protein S6 |
decreases expression |
ISO |
Gold results in decreased expression of MRPS6 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr16:91,855,224...91,909,115
Ensembl chr16:91,855,158...91,909,115
|
|
G |
Mt1 |
metallothionein 1 |
increases expression |
ISO |
Gold results in increased expression of MT1X mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:94,905,214...94,906,955
Ensembl chr 8:94,905,710...94,906,955
|
|
G |
Mt2 |
metallothionein 2 |
increases expression |
ISO |
Gold results in increased expression of MT2A mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:94,899,246...94,900,195
Ensembl chr 8:94,899,292...94,900,196
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of MTHFR mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 4:148,123,534...148,144,019
Ensembl chr 4:148,123,534...148,144,008
|
|
G |
Mtmr6 |
myotubularin related protein 6 |
decreases expression |
ISO |
Gold results in decreased expression of MTMR6 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr14:60,488,941...60,539,820
Ensembl chr14:60,502,677...60,539,819
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
multiple interactions |
ISO |
[Quercetin analog co-treated with Gold analog] results in decreased phosphorylation of MTOR protein |
CTD |
PMID:27470402 |
|
NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140
|
|
G |
Mtss1 |
MTSS I-BAR domain containing 1 |
increases expression |
ISO |
Gold results in increased expression of MTSS1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr15:58,813,083...58,955,805
Ensembl chr15:58,813,083...58,953,854
|
|
G |
Mttp |
microsomal triglyceride transfer protein |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of MTTP mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 3:137,795,616...137,849,179
Ensembl chr 3:137,795,615...137,850,729
|
|
G |
Mycl |
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of MYCL mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 4:122,889,414...122,896,278
Ensembl chr 4:122,889,445...122,896,278
|
|
G |
Mynn |
myoneurin |
decreases expression |
ISO |
Gold results in decreased expression of MYNN mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:30,656,212...30,674,022
Ensembl chr 3:30,656,214...30,674,022
|
|
G |
Napepld |
N-acyl phosphatidylethanolamine phospholipase D |
decreases expression |
ISO |
Gold results in decreased expression of NAPEPLD mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 5:21,867,899...21,906,620
Ensembl chr 5:21,867,899...21,906,394
|
|
G |
Nceh1 |
neutral cholesterol ester hydrolase 1 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of NCEH1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 3:27,237,153...27,299,112
Ensembl chr 3:27,237,114...27,338,757
|
|
G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
increases activity increases expression |
ISO |
Gold results in increased activity of NFE2L2 promoter Gold analog results in increased expression of NFE2L2 mRNA; Gold analog results in increased expression of NFE2L2 protein |
CTD |
PMID:21643505 PMID:36057382 |
|
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
|
|
G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
decreases expression |
ISO |
Gold analog results in decreased expression of NFKB1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 3:135,290,416...135,397,422
Ensembl chr 3:135,290,416...135,397,308
|
|
G |
Nfkbid |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, delta |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of NFKBID mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 7:30,121,156...30,128,173
Ensembl chr 7:30,121,157...30,128,171
|
|
G |
Nfkbiz |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, zeta |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of NFKBIZ mRNA |
CTD |
PMID:19695318 |
|
NCBI chr16:55,631,740...55,659,018
Ensembl chr16:55,631,738...55,659,262
|
|
G |
Nipbl |
NIPBL cohesin loading factor |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of NIPBL mRNA |
CTD |
PMID:19695318 |
|
NCBI chr15:8,319,308...8,494,799
Ensembl chr15:8,320,101...8,473,947
|
|
G |
Nos2 |
nitric oxide synthase 2, inducible |
increases expression |
ISO |
Gold results in increased expression of NOS2 protein |
CTD |
PMID:24022940 |
|
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
|
|
G |
Nploc4 |
NPL4 homolog, ubiquitin recognition factor |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of NPLOC4 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr11:120,270,624...120,328,526
Ensembl chr11:120,271,196...120,328,534
|
|
G |
Npm1 |
nucleophosmin 1 |
decreases expression |
ISO |
Gold results in decreased expression of NPM1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr11:33,102,498...33,114,143
Ensembl chr11:33,102,287...33,113,206
|
|
G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
multiple interactions increases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in increased expression of NQO1 mRNA Gold analog results in increased expression of NQO1 mRNA; Gold results in increased expression of NQO1 mRNA |
CTD |
PMID:28433809 PMID:29705079 PMID:36057382 |
|
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
decreases expression |
ISO |
Gold analog results in decreased expression of NR0B2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 4:133,280,687...133,283,997
Ensembl chr 4:133,280,687...133,283,847
|
|
G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of NR4A1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr15:101,151,783...101,172,676
Ensembl chr15:101,152,150...101,172,676
|
|
G |
Nrcam |
neuronal cell adhesion molecule |
increases expression |
ISO |
Gold results in increased expression of NRCAM mRNA |
CTD |
PMID:29705079 |
|
NCBI chr12:44,375,568...44,651,977
Ensembl chr12:44,375,668...44,648,747
|
|
G |
Nrip1 |
nuclear receptor interacting protein 1 |
increases expression |
ISO |
Gold results in increased expression of NRIP1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr16:76,084,291...76,170,930
Ensembl chr16:76,084,288...76,170,715
|
|
G |
Ntn4 |
netrin 4 |
increases expression |
ISO |
Gold results in increased expression of NTN4 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr10:93,476,911...93,581,834
Ensembl chr10:93,476,543...93,583,069
|
|
G |
Nucb1 |
nucleobindin 1 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of NUCB1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 7:45,142,300...45,159,813
Ensembl chr 7:45,139,882...45,159,830
|
|
G |
Nudt1 |
nudix hydrolase 1 |
decreases expression |
ISO |
Gold analog results in decreased expression of NUDT1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 5:140,307,375...140,323,892
Ensembl chr 5:140,307,411...140,323,892
|
|
G |
Nudt12 |
nudix hydrolase 12 |
decreases expression |
ISO |
Gold results in decreased expression of NUDT12 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr17:59,307,104...59,320,317
Ensembl chr17:59,306,613...59,320,367
|
|
G |
Nudt13 |
nudix hydrolase 13 |
decreases expression |
ISO |
Gold analog results in decreased expression of NUDT13 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr14:20,344,709...20,367,652
Ensembl chr14:20,344,765...20,367,646
|
|
G |
Nup210 |
nucleoporin 210 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of NUP210 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 6:90,990,049...91,095,920
Ensembl chr 6:90,990,050...91,093,811
|
|
G |
Obi1 |
ORC ubiquitin ligase 1 |
decreases expression |
ISO |
Gold results in decreased expression of OBI1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr14:104,714,970...104,760,148
Ensembl chr14:104,714,972...104,760,081
|
|
G |
Odr4 |
odr4 GPCR localization factor homolog |
decreases expression |
ISO |
Gold results in decreased expression of ODR4 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:150,237,056...150,268,831
Ensembl chr 1:150,237,056...150,268,831
|
|
G |
Ogdh |
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of OGDH mRNA |
CTD |
PMID:28433809 |
|
NCBI chr11:6,241,597...6,309,094
Ensembl chr11:6,241,633...6,306,642
|
|
G |
Ogg1 |
8-oxoguanine DNA-glycosylase 1 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of OGG1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 6:113,303,959...113,311,149
Ensembl chr 6:113,303,933...113,312,029
|
|
G |
Or52n20 |
olfactory receptor family 52 subfamily N member 20 |
increases expression |
ISO |
Gold results in increased expression of PNLIPRP3 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 7:104,319,911...104,320,879
Ensembl chr 7:104,315,960...104,324,155
|
|
G |
Orc4 |
origin recognition complex, subunit 4 |
decreases expression |
ISO |
Gold results in decreased expression of ORC4 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:48,792,836...48,840,287
Ensembl chr 2:48,792,836...48,840,289
|
|
G |
Os9 |
amplified in osteosarcoma |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of OS9 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr10:126,928,880...126,957,029
Ensembl chr10:126,931,519...126,957,000
|
|
G |
Osgin1 |
oxidative stress induced growth inhibitor 1 |
increases expression |
ISO |
Gold results in increased expression of OSGIN1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:120,160,874...120,172,996
Ensembl chr 8:120,160,863...120,172,995
|
|
G |
P4hb |
prolyl 4-hydroxylase, beta polypeptide |
decreases expression |
EXP |
Gold analog results in decreased expression of P4HB protein |
CTD |
PMID:24780912 |
|
NCBI chr11:120,451,124...120,464,079
Ensembl chr11:120,451,124...120,464,079
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
multiple interactions decreases expression |
ISO |
Organogold Compounds promotes the reaction [Gold binds to PARP1 protein] Gold analog results in decreased expression of PARP1 mRNA |
CTD |
PMID:21370912 PMID:36057382 |
|
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
|
|
G |
Pcbp1 |
poly(rC) binding protein 1 |
decreases expression |
EXP |
Gold analog results in decreased expression of PCBP1 protein |
CTD |
PMID:24780912 |
|
NCBI chr 6:86,501,462...86,503,171
Ensembl chr 6:86,501,474...86,503,303
|
|
G |
Pcca |
propionyl-Coenzyme A carboxylase, alpha polypeptide |
decreases expression |
ISO |
Gold analog results in decreased expression of PCCA mRNA |
CTD |
PMID:36057382 |
|
NCBI chr14:122,721,822...123,127,372
Ensembl chr14:122,771,736...123,128,512
|
|
G |
Pcgf5 |
polycomb group ring finger 5 |
decreases expression |
ISO |
Gold results in decreased expression of PCGF5 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr19:36,325,729...36,438,370
Ensembl chr19:36,325,709...36,438,370
|
|
G |
Pcgf6 |
polycomb group ring finger 6 |
decreases expression |
ISO |
Gold results in decreased expression of PCGF6 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr19:47,022,056...47,039,379
Ensembl chr19:47,022,056...47,039,345
|
|
G |
Pcna |
proliferating cell nuclear antigen |
decreases expression |
ISO |
Gold analog results in decreased expression of PCNA mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 2:132,091,206...132,095,100
Ensembl chr 2:132,091,082...132,095,234
|
|
G |
Pde4b |
phosphodiesterase 4B, cAMP specific |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of PDE4B mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 4:101,944,529...102,464,459
Ensembl chr 4:101,944,740...102,464,456
|
|
G |
Per3 |
period circadian clock 3 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of PER3 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 4:151,081,475...151,129,167
Ensembl chr 4:151,088,109...151,129,122
|
|
G |
Piga |
phosphatidylinositol glycan anchor biosynthesis, class A |
decreases expression |
ISO |
Gold results in decreased expression of PIGA mRNA |
CTD |
PMID:25523186 |
|
NCBI chr X:163,202,814...163,216,912
Ensembl chr X:163,202,783...163,216,912
|
|
G |
Pigf |
phosphatidylinositol glycan anchor biosynthesis, class F |
decreases expression |
ISO |
Gold results in decreased expression of PIGF mRNA |
CTD |
PMID:25523186 |
|
NCBI chr17:87,304,686...87,332,972
Ensembl chr17:87,304,684...87,332,834
|
|
G |
Pigk |
phosphatidylinositol glycan anchor biosynthesis, class K |
decreases expression |
ISO |
Gold results in decreased expression of PIGK mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:152,419,718...152,548,705
Ensembl chr 3:152,419,737...152,686,045
|
|
G |
Pigyl |
phosphatidylinositol glycan anchor biosynthesis, class Y-like |
decreases expression |
ISO |
Gold results in decreased expression of PIGY mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 9:22,068,142...22,069,651
Ensembl chr 9:22,068,142...22,069,654
|
|
G |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of PIK3R1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr13:101,817,269...101,904,725
Ensembl chr13:101,817,071...101,904,725
|
|
G |
Pkm |
pyruvate kinase, muscle |
decreases expression |
EXP |
Gold analog results in decreased expression of PKM protein |
CTD |
PMID:24780912 |
|
NCBI chr 9:59,563,859...59,586,655
Ensembl chr 9:59,563,651...59,586,658
|
|
G |
Pla2g6 |
phospholipase A2, group VI |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of PLA2G6 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr15:79,170,428...79,212,915
Ensembl chr15:79,170,428...79,212,590
|
|
G |
Plekhf2 |
pleckstrin homology domain containing, family F (with FYVE domain) member 2 |
decreases expression |
ISO |
Gold results in decreased expression of PLEKHF2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:10,988,662...11,007,619
Ensembl chr 4:10,988,662...11,007,927
|
|
G |
Plin3 |
perilipin 3 |
increases expression |
EXP |
Gold analog results in increased expression of PLIN3 protein |
CTD |
PMID:24780912 |
|
NCBI chr17:56,585,962...56,597,511
Ensembl chr17:56,584,476...56,599,873
|
|
G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of PMAIP1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr18:66,591,675...66,598,629
Ensembl chr18:66,591,604...66,598,636
|
|
G |
Polk |
polymerase (DNA directed), kappa |
decreases expression |
ISO |
Gold results in decreased expression of POLK mRNA |
CTD |
PMID:25523186 |
|
NCBI chr13:96,617,195...96,679,087
Ensembl chr13:96,617,198...96,679,087
|
|
G |
Polr2k |
polymerase (RNA) II (DNA directed) polypeptide K |
decreases expression |
ISO |
Gold results in decreased expression of POLR2K mRNA |
CTD |
PMID:25523186 |
|
NCBI chr15:36,174,156...36,177,158
Ensembl chr15:36,174,156...36,177,156
|
|
G |
Popdc1 |
popeye domain cAMP effector 1 |
increases expression |
ISO |
Gold results in increased expression of POPDC1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr10:45,211,783...45,248,580
Ensembl chr10:45,211,868...45,248,575
|
|
G |
Popdc3 |
popeye domain containing 3 |
increases expression |
ISO |
Gold results in increased expression of POPDC3 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr10:45,165,401...45,194,546
Ensembl chr10:45,054,194...45,194,548
|
|
G |
Por |
cytochrome p450 oxidoreductase |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of POR mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 5:135,698,894...135,764,180
Ensembl chr 5:135,698,887...135,764,180
|
|
G |
Ppp1cb |
protein phosphatase 1 catalytic subunit beta |
decreases expression |
ISO |
Gold results in decreased expression of PPP1CB mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 5:32,616,192...32,651,057
Ensembl chr 5:32,616,187...32,674,777
|
|
G |
Ppp2r1a |
protein phosphatase 2, regulatory subunit A, alpha |
decreases expression |
EXP |
Gold analog results in decreased expression of PPP2R1A protein |
CTD |
PMID:24780912 |
|
NCBI chr17:21,165,716...21,186,167
Ensembl chr17:21,165,573...21,186,178
|
|
G |
Ppp2r5e |
protein phosphatase 2, regulatory subunit B', epsilon |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of PPP2R5E mRNA |
CTD |
PMID:19695318 |
|
NCBI chr12:75,496,237...75,643,064
Ensembl chr12:75,497,655...75,643,019
|
|
G |
Prdx1 |
peroxiredoxin 1 |
decreases expression increases expression |
EXP ISO |
Gold analog results in decreased expression of PRDX1 protein Gold analog results in increased expression of PRDX1 mRNA |
CTD |
PMID:24780912 PMID:36057382 |
|
NCBI chr 4:116,542,796...116,557,196
Ensembl chr 4:116,542,741...116,558,019
|
|
G |
Prrc2a |
proline-rich coiled-coil 2A |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of PRRC2A mRNA |
CTD |
PMID:19695318 |
|
NCBI chr17:35,368,052...35,384,877
Ensembl chr17:35,368,052...35,383,873
|
|
G |
Psat1 |
phosphoserine aminotransferase 1 |
decreases expression |
EXP |
Gold analog results in decreased expression of PSAT1 protein |
CTD |
PMID:24780912 |
|
NCBI chr19:15,882,487...15,902,423
Ensembl chr19:15,882,042...15,924,701
|
|
G |
Psmd14 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 14 |
decreases expression |
ISO |
Gold results in decreased expression of PSMD14 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:61,542,038...61,630,720
Ensembl chr 2:61,542,038...61,630,720
|
|
G |
Ptbp2 |
polypyrimidine tract binding protein 2 |
decreases expression |
ISO |
Gold results in decreased expression of PTBP2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:119,512,390...119,578,296
Ensembl chr 3:119,512,391...119,578,115
|
|
G |
Ptgr1 |
prostaglandin reductase 1 |
increases expression |
ISO |
Gold results in increased expression of PTGR1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 4:58,965,590...58,987,131
Ensembl chr 4:58,965,439...58,987,119
|
|
G |
Ptgr2 |
prostaglandin reductase 2 |
decreases expression |
ISO |
Gold results in decreased expression of PTGR2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr12:84,332,011...84,362,606
Ensembl chr12:84,332,006...84,362,606
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions increases expression |
EXP ISO |
[Gold co-treated with Silicon Dioxide] results in increased expression of PTGS2 mRNA [Polyethyleneimine binds to Gold] which results in decreased expression of PTGS2 mRNA Gold results in increased expression of PTGS2 mRNA |
CTD |
PMID:22155353 PMID:28433809 |
|
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
|
|
G |
Ptprc |
protein tyrosine phosphatase receptor type C |
increases expression |
ISO |
Gold analog results in increased expression of PTPRC mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 1:137,990,601...138,103,491
Ensembl chr 1:137,990,599...138,103,446
|
|
G |
Pts |
6-pyruvoyl-tetrahydropterin synthase |
decreases expression |
ISO |
Gold results in decreased expression of PTS mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 9:50,432,917...50,440,017
Ensembl chr 9:50,432,917...50,440,024
|
|
G |
Pvr |
poliovirus receptor |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of PVR mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 7:19,637,503...19,655,068
Ensembl chr 7:19,637,503...19,655,085
|
|
G |
Rab11a |
RAB11A, member RAS oncogene family |
decreases expression |
ISO |
Gold results in decreased expression of RAB11A mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 9:64,622,582...64,645,038
Ensembl chr 9:64,622,581...64,645,040
|
|
G |
Rab18 |
RAB18, member RAS oncogene family |
decreases expression |
ISO |
Gold results in decreased expression of RAB18 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr18:6,765,167...6,791,606
Ensembl chr18:6,733,905...6,794,429
|
|
G |
Rabggtb |
Rab geranylgeranyl transferase, b subunit |
decreases expression |
ISO |
Gold results in decreased expression of RABGGTB mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:153,612,926...153,618,603
Ensembl chr 3:153,612,924...153,618,646
|
|
G |
Rad51 |
RAD51 recombinase |
decreases expression |
ISO |
Gold analog results in decreased expression of RAD51 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 2:118,943,295...118,966,554
Ensembl chr 2:118,943,274...118,977,926
|
|
G |
Rad51b |
RAD51 paralog B |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of RAD51B mRNA |
CTD |
PMID:19695318 |
|
NCBI chr12:79,344,032...79,895,034
Ensembl chr12:79,344,056...79,861,464
|
|
G |
Rai14 |
retinoic acid induced 14 |
increases expression |
ISO |
Gold results in increased expression of RAI14 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr15:10,569,057...10,719,353
Ensembl chr15:10,569,055...10,714,710
|
|
G |
Rb1cc1 |
RB1-inducible coiled-coil 1 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of RB1CC1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 1:6,284,858...6,346,599
Ensembl chr 1:6,276,421...6,346,872
|
|
G |
Rbm12 |
RNA binding motif protein 12 |
decreases expression |
ISO |
Gold results in decreased expression of RBM12 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:155,933,876...155,953,847
Ensembl chr 2:155,933,878...155,953,898
|
|
G |
Rbp1 |
retinol binding protein 1, cellular |
increases expression |
ISO |
Gold results in increased expression of RBP1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 9:98,305,014...98,328,604
Ensembl chr 9:98,305,014...98,328,628
|
|
G |
Rc3h1 |
RING CCCH (C3H) domains 1 |
decreases expression |
ISO |
Gold results in decreased expression of RC3H1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:160,733,981...160,802,546
Ensembl chr 1:160,733,988...160,802,548
|
|
G |
Rdx |
radixin |
decreases expression |
ISO |
Gold analog results in decreased expression of RDX mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 9:51,958,450...52,000,038
Ensembl chr 9:51,958,473...52,011,763
|
|
G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
multiple interactions |
ISO |
[Gallic Acid binds to Gold] inhibits the reaction [EGF protein results in increased phosphorylation of RELA protein] |
CTD |
PMID:27634460 |
|
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
|
|
G |
Rfk |
riboflavin kinase |
decreases expression |
ISO |
Gold results in decreased expression of RFK mRNA |
CTD |
PMID:25523186 |
|
NCBI chr19:17,371,407...17,378,713
Ensembl chr19:17,371,407...17,378,713
|
|
G |
Rhou |
ras homolog family member U |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of RHOU mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 8:124,380,609...124,390,622
Ensembl chr 8:124,380,668...124,390,623
|
|
G |
Rnf11 |
ring finger protein 11 |
decreases expression |
ISO |
Gold results in decreased expression of RNF11 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:109,310,054...109,333,702
Ensembl chr 4:109,308,295...109,341,925
|
|
G |
Rnf13 |
ring finger protein 13 |
decreases expression |
ISO |
Gold results in decreased expression of RNF13 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:57,643,468...57,742,846
Ensembl chr 3:57,643,483...57,742,654
|
|
G |
Rnf138 |
ring finger protein 138 |
decreases expression |
ISO |
Gold results in decreased expression of RNF138 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr18:21,134,202...21,161,281
Ensembl chr18:21,134,398...21,161,281
|
|
G |
Rnf149 |
ring finger protein 149 |
decreases expression |
ISO |
Gold results in decreased expression of RNF149 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:39,590,375...39,616,885
Ensembl chr 1:39,590,377...39,616,486
|
|
G |
Rnf2 |
ring finger protein 2 |
decreases expression |
ISO |
Gold results in decreased expression of RNF2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:151,345,159...151,376,562
Ensembl chr 1:151,333,755...151,376,706
|
|
G |
Rnft1 |
ring finger protein, transmembrane 1 |
decreases expression |
ISO |
Gold results in decreased expression of RNFT1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr11:86,375,483...86,389,833
Ensembl chr11:86,375,483...86,389,851
|
|
G |
Ro60 |
Ro60, Y RNA binding protein |
decreases expression |
ISO |
Gold results in decreased expression of RO60 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:143,626,528...143,652,794
Ensembl chr 1:143,626,528...143,652,806
|
|
G |
Rp2 |
retinitis pigmentosa 2 homolog |
decreases expression |
ISO |
Gold results in decreased expression of RP2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr X:20,230,778...20,271,873
Ensembl chr X:20,230,720...20,271,892
|
|
G |
Rps27l |
ribosomal protein S27-like |
decreases expression |
ISO |
Gold results in decreased expression of RPS27L mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 9:66,851,906...66,856,804
Ensembl chr 9:66,853,368...66,856,798
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase, polypeptide 1 |
multiple interactions |
ISO |
[Quercetin analog co-treated with Gold analog] results in decreased expression of RPS6KB1 protein |
CTD |
PMID:27470402 |
|
NCBI chr11:86,389,695...86,435,711
Ensembl chr11:86,389,697...86,435,631
|
|
G |
Rtn4 |
reticulon 4 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of RTN4 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr11:29,642,898...29,694,414
Ensembl chr11:29,642,947...29,694,331
|
|
G |
Saa1 |
serum amyloid A 1 |
increases expression multiple interactions |
ISO |
Gold results in increased expression of SAA1 mRNA Gold promotes the reaction [SAA1 protein binds to TLR2 protein] |
CTD |
PMID:29705079 |
|
NCBI chr 7:46,389,921...46,392,404
Ensembl chr 7:46,389,921...46,392,404
|
|
G |
Sar1b |
secretion associated Ras related GTPase 1B |
decreases expression |
ISO |
Gold results in decreased expression of SAR1B mRNA |
CTD |
PMID:25523186 |
|
NCBI chr11:51,654,490...51,682,780
Ensembl chr11:51,654,514...51,682,752
|
|
G |
Sarnp |
SAP domain containing ribonucleoprotein |
decreases expression |
ISO |
Gold results in decreased expression of SARNP mRNA |
CTD |
PMID:25523186 |
|
NCBI chr10:128,657,633...128,713,507
Ensembl chr10:128,653,202...128,713,498
|
|
G |
Scoc |
short coiled-coil protein |
decreases expression |
ISO |
Gold results in decreased expression of SCOC mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:84,161,121...84,185,055
Ensembl chr 8:84,156,713...84,185,020
|
|
G |
Scp2 |
sterol carrier protein 2, liver |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of SCP2 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 4:107,901,027...108,002,168
Ensembl chr 4:107,901,036...108,002,195
|
|
G |
Sec23a |
SEC23 homolog A, COPII coat complex component |
decreases expression |
ISO |
Gold results in decreased expression of SEC23A mRNA |
CTD |
PMID:25523186 |
|
NCBI chr12:59,005,170...59,058,803
Ensembl chr12:59,005,169...59,058,803
|
|
G |
Sec24a |
SEC24 homolog A, COPII coat complex component |
decreases expression |
ISO |
Gold results in decreased expression of SEC24A mRNA |
CTD |
PMID:25523186 |
|
NCBI chr11:51,583,090...51,649,172
Ensembl chr11:51,583,091...51,654,461
|
|
G |
Sel1l3 |
sel-1 suppressor of lin-12-like 3 (C. elegans) |
increases expression |
ISO |
Gold results in increased expression of SEL1L3 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 5:53,264,425...53,370,794
Ensembl chr 5:53,264,425...53,371,269
|
|
G |
Selenot |
selenoprotein T |
decreases expression |
ISO |
Gold results in decreased expression of SELENOT mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:58,484,057...58,500,965
Ensembl chr 3:58,484,057...58,500,554
|
|
G |
Septin8 |
septin 8 |
decreases expression |
EXP |
Gold analog results in decreased expression of SEPTIN8 protein |
CTD |
PMID:24780912 |
|
NCBI chr11:53,410,224...53,440,432
Ensembl chr11:53,410,084...53,440,392
|
|
G |
Serp1 |
stress-associated endoplasmic reticulum protein 1 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in increased expression of SERP1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 3:58,429,390...58,433,305
Ensembl chr 3:58,427,238...58,433,313
|
|
G |
Serpine1 |
serine (or cysteine) peptidase inhibitor, clade E, member 1 |
increases expression |
ISO |
Gold results in increased expression of SERPINE1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
|
|
G |
Serpinh1 |
serine (or cysteine) peptidase inhibitor, clade H, member 1 |
decreases expression |
EXP |
Gold analog results in decreased expression of SERPINH1 protein |
CTD |
PMID:24780912 |
|
NCBI chr 7:98,994,583...99,002,321
Ensembl chr 7:98,994,583...99,002,446
|
|
G |
Sh3kbp1 |
SH3-domain kinase binding protein 1 |
increases expression |
ISO |
Gold results in increased expression of SH3KBP1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr X:158,409,888...158,758,916
Ensembl chr X:158,410,268...158,761,065
|
|
G |
Slc25a24 |
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 24 |
decreases expression |
EXP |
Gold analog results in decreased expression of SLC25A24 protein |
CTD |
PMID:24780912 |
|
NCBI chr 3:109,030,465...109,075,725
Ensembl chr 3:109,030,465...109,075,773
|
|
G |
Slirp |
SRA stem-loop interacting RNA binding protein |
decreases expression |
ISO |
Gold results in decreased expression of SLIRP mRNA |
CTD |
PMID:25523186 |
|
NCBI chr12:87,490,666...87,496,694
Ensembl chr12:87,490,666...87,498,976
|
|
G |
Smarcad1 |
SNF2 related chromatin remodeling ATPase with DExD box 1 |
decreases expression |
ISO |
Gold results in decreased expression of SMARCAD1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 6:65,019,577...65,093,045
Ensembl chr 6:65,019,567...65,093,045
|
|
G |
Smc4 |
structural maintenance of chromosomes 4 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of SMC4 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 3:68,912,071...68,941,956
Ensembl chr 3:68,912,071...68,941,956
|
|
G |
Smc6 |
structural maintenance of chromosomes 6 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of SMC6 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr12:11,315,887...11,369,786
Ensembl chr12:11,315,887...11,369,786
|
|
G |
Snrpb2 |
U2 small nuclear ribonucleoprotein B |
decreases expression |
ISO |
Gold results in decreased expression of SNRPB2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:142,904,989...142,913,972
Ensembl chr 2:142,904,959...142,914,773
|
|
G |
Snx6 |
sorting nexin 6 |
decreases expression |
ISO |
Gold results in decreased expression of SNX6 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr12:54,793,124...54,842,464
Ensembl chr12:54,793,134...54,842,488
|
|
G |
Sod1 |
superoxide dismutase 1, soluble |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of SOD1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
|
|
G |
Sp100 |
nuclear antigen Sp100 |
decreases expression |
ISO |
Gold results in decreased expression of SP100 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:85,577,683...85,637,719
Ensembl chr 1:85,577,709...85,637,719
|
|
G |
Sp3 |
trans-acting transcription factor 3 |
decreases expression |
ISO |
Gold results in decreased expression of SP3 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:72,766,774...72,810,790
Ensembl chr 2:72,766,771...72,810,790
|
|
G |
Spast |
spastin |
decreases expression |
ISO |
Gold results in decreased expression of SPAST mRNA |
CTD |
PMID:25523186 |
|
NCBI chr17:74,643,805...74,698,110
Ensembl chr17:74,645,982...74,698,110
|
|
G |
Spata2 |
spermatogenesis associated 2 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of SPATA2 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 2:167,323,053...167,334,804
Ensembl chr 2:167,323,053...167,334,807
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of SREBF1 mRNA Gold analog results in decreased expression of SREBF1 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr11:60,089,910...60,113,407
Ensembl chr11:60,089,915...60,113,407
|
|
G |
Srek1ip1 |
splicing regulatory glutamine/lysine-rich protein 1interacting protein 1 |
decreases expression |
ISO |
Gold results in decreased expression of SREK1IP1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr13:104,953,696...104,975,805
Ensembl chr13:104,928,992...104,975,782
|
|
G |
Srp9 |
signal recognition particle 9 |
decreases expression |
ISO |
Gold results in decreased expression of SRP9 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:181,952,302...181,959,980
Ensembl chr 1:181,952,302...181,959,972
|
|
G |
Srsf10 |
serine and arginine-rich splicing factor 10 |
decreases expression |
ISO |
Gold results in decreased expression of SRSF10 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:135,582,454...135,597,219
Ensembl chr 4:135,583,058...135,597,219
|
|
G |
Srsf3 |
serine and arginine-rich splicing factor 3 |
decreases expression |
ISO |
Gold results in decreased expression of SRSF3 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr17:29,251,634...29,262,346
Ensembl chr17:29,251,602...29,262,347
|
|
G |
Srsf7 |
serine and arginine-rich splicing factor 7 |
decreases expression |
ISO |
Gold results in decreased expression of SRSF7 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr17:80,507,509...80,514,734
Ensembl chr17:80,507,509...80,514,736
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
multiple interactions increases expression |
EXP |
[Gold co-treated with Silicon Dioxide] results in increased expression of STAT1 mRNA Gold results in increased expression of STAT1 mRNA |
CTD |
PMID:22155353 |
|
NCBI chr 1:52,158,588...52,201,024
Ensembl chr 1:52,158,599...52,201,024
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
increases expression multiple interactions |
EXP |
Gold results in increased expression of STAT3 mRNA [Gold co-treated with Silicon Dioxide] results in increased expression of STAT3 mRNA |
CTD |
PMID:22155353 |
|
NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366
|
|
G |
Stau2 |
staufen double-stranded RNA binding protein 2 |
decreases expression |
ISO |
Gold results in decreased expression of STAU2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:16,299,027...16,591,228
Ensembl chr 1:16,298,898...16,590,336
|
|
G |
Stbd1 |
starch binding domain 1 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of STBD1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 5:92,750,910...92,754,438
Ensembl chr 5:92,750,900...92,754,438
|
|
G |
Steap1 |
six transmembrane epithelial antigen of the prostate 1 |
decreases expression |
ISO |
Gold results in decreased expression of STEAP1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 5:5,786,322...5,799,317
Ensembl chr 5:5,786,317...5,799,326
|
|
G |
Stk26 |
serine/threonine kinase 26 |
decreases expression |
ISO |
Gold results in decreased expression of STK26 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr X:49,930,052...49,981,980
Ensembl chr X:49,929,924...49,981,974
|
|
G |
Sucla2 |
succinate-Coenzyme A ligase, ADP-forming, beta subunit |
decreases expression |
ISO |
Gold analog results in decreased expression of SUCLA2 mRNA; Gold results in decreased expression of SUCLA2 mRNA |
CTD |
PMID:25523186 PMID:36057382 |
|
NCBI chr14:73,790,226...73,833,584
Ensembl chr14:73,762,759...73,833,582
|
|
G |
Syt1 |
synaptotagmin I |
decreases expression |
ISO |
Gold analog results in decreased expression of SYT1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr10:108,333,511...108,846,852
Ensembl chr10:108,333,511...108,846,843
|
|
G |
Syvn1 |
synovial apoptosis inhibitor 1, synoviolin |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of SYVN1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr19:6,096,586...6,103,748
Ensembl chr19:6,096,606...6,103,742
|
|
G |
Tacstd2 |
tumor-associated calcium signal transducer 2 |
increases expression |
ISO |
Gold results in increased expression of TACSTD2 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 6:67,511,043...67,512,806
Ensembl chr 6:67,511,046...67,512,780
|
|
G |
Tada1 |
transcriptional adaptor 1 |
decreases expression |
ISO |
Gold results in decreased expression of TADA1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:166,206,736...166,221,190
Ensembl chr 1:166,206,666...166,221,190
|
|
G |
Taf9b |
TATA-box binding protein associated factor 9B |
decreases expression |
ISO |
Gold results in decreased expression of TAF9B mRNA |
CTD |
PMID:25523186 |
|
NCBI chr X:105,250,480...105,264,764
Ensembl chr X:105,250,489...105,264,764
|
|
G |
Tagln |
transgelin |
decreases expression |
ISO |
Gold analog results in decreased expression of TAGLN mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 9:45,840,926...45,847,356
Ensembl chr 9:45,840,917...45,847,356
|
|
G |
Tbl1xr1 |
transducin (beta)-like 1X-linked receptor 1 |
decreases expression |
ISO |
Gold results in decreased expression of TBL1XR1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:22,130,756...22,270,758
Ensembl chr 3:22,130,816...22,270,758
|
|
G |
Tcea1 |
transcription elongation factor A (SII) 1 |
decreases expression |
ISO |
Gold results in decreased expression of TCEA1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:4,927,917...4,968,132
Ensembl chr 1:4,928,037...4,968,132
|
|
G |
Tdo2 |
tryptophan 2,3-dioxygenase |
decreases expression |
ISO |
Gold results in decreased expression of TDO2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:81,865,719...81,883,035
Ensembl chr 3:81,864,397...81,883,509
|
|
G |
Tex30 |
testis expressed 30 |
decreases expression |
ISO |
Gold results in decreased expression of TEX30 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:44,125,773...44,141,650
Ensembl chr 1:44,125,773...44,141,601
|
|
G |
Tfec |
transcription factor EC |
decreases expression |
ISO |
Gold results in decreased expression of TFEC mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 6:16,830,926...16,898,463
Ensembl chr 6:16,833,372...16,898,440
|
|
G |
Tfpi2 |
tissue factor pathway inhibitor 2 |
increases expression |
ISO |
Gold results in increased expression of TFPI2 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 6:3,962,589...3,988,977
Ensembl chr 6:3,962,595...3,988,919
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of TGFB1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
|
|
G |
Thap1 |
THAP domain containing, apoptosis associated protein 1 |
decreases expression |
ISO |
Gold results in decreased expression of THAP1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:26,648,197...26,654,179
Ensembl chr 8:26,648,169...26,654,179
|
|
G |
Tia1 |
cytotoxic granule-associated RNA binding protein 1 |
decreases expression |
ISO |
Gold results in decreased expression of TIA1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 6:86,381,001...86,410,387
Ensembl chr 6:86,381,201...86,410,387
|
|
G |
Tkt |
transketolase |
decreases expression |
EXP |
Gold analog results in decreased expression of TKT protein |
CTD |
PMID:24780912 |
|
NCBI chr14:30,271,088...30,296,681
Ensembl chr14:30,270,316...30,296,677
|
|
G |
Tlk1 |
tousled-like kinase 1 |
increases expression |
ISO |
Gold results in increased expression of TLK1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 2:70,542,751...70,656,505
Ensembl chr 2:70,542,751...70,656,072
|
|
G |
Tlr2 |
toll-like receptor 2 |
increases expression multiple interactions |
ISO |
Gold results in increased expression of TLR2 mRNA Gold promotes the reaction [SAA1 protein binds to TLR2 protein] |
CTD |
PMID:29705079 |
|
NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074
|
|
G |
Tm4sf1 |
transmembrane 4 superfamily member 1 |
increases expression |
ISO |
Gold results in increased expression of TM4SF1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 3:57,193,038...57,295,150
Ensembl chr 3:57,193,032...57,209,409 Ensembl chr 3:57,193,032...57,209,409
|
|
G |
Tmed10 |
transmembrane p24 trafficking protein 10 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of TMED10 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr12:85,387,388...85,421,491
Ensembl chr12:85,387,388...85,421,621
|
|
G |
Tnf |
tumor necrosis factor |
increases secretion multiple interactions |
EXP |
Gold results in increased secretion of TNF protein [Gold co-treated with Silicon Dioxide] results in increased secretion of TNF protein |
CTD |
PMID:22155353 |
|
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
G |
Tnfaip3 |
tumor necrosis factor, alpha-induced protein 3 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of TNFAIP3 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr10:18,876,658...18,891,158
Ensembl chr10:18,876,658...18,891,405
|
|
G |
Tnfaip8l1 |
tumor necrosis factor, alpha-induced protein 8-like 1 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of TNFAIP8L1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr17:56,469,439...56,491,249
Ensembl chr17:56,469,477...56,480,955
|
|
G |
Tnfrsf10b |
tumor necrosis factor receptor superfamily, member 10b |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of TNFRSF10A mRNA |
CTD |
PMID:28433809 |
|
NCBI chr14:70,004,921...70,021,860
Ensembl chr14:70,004,921...70,021,860
|
|
G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of TNFRSF1A mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 6:125,326,686...125,339,446
Ensembl chr 6:125,326,325...125,339,447
|
|
G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
decreases expression |
ISO |
Gold analog results in decreased expression of TNFSF10 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 3:27,371,226...27,393,814
Ensembl chr 3:27,371,177...27,396,576
|
|
G |
Tpt1 |
tumor protein, translationally-controlled 1 |
decreases expression |
EXP |
Gold analog results in decreased expression of TPT1 protein |
CTD |
PMID:24780912 |
|
NCBI chr14:76,082,771...76,085,743
Ensembl chr14:76,082,533...76,085,965
|
|
G |
Trim23 |
tripartite motif-containing 23 |
decreases expression |
ISO |
Gold results in decreased expression of TRIM23 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr13:104,315,187...104,339,983
Ensembl chr13:104,315,305...104,339,880
|
|
G |
Trmt13 |
tRNA methyltransferase 13 |
decreases expression |
ISO |
Gold results in decreased expression of TRMT13 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:116,365,706...116,408,236
Ensembl chr 3:116,374,742...116,408,236
|
|
G |
Trp53 |
transformation related protein 53 |
increases expression |
EXP |
Gold analog results in increased expression of TRP53 mRNA |
CTD |
PMID:22486372 |
|
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
|
|
G |
Trub1 |
TruB pseudouridine (psi) synthase family member 1 |
decreases expression |
ISO |
Gold results in decreased expression of TRUB1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr19:57,441,323...57,479,437
Ensembl chr19:57,441,344...57,479,437
|
|
G |
Tuba1a |
tubulin, alpha 1A |
decreases expression |
EXP |
Gold analog results in decreased expression of TUBA1A protein |
CTD |
PMID:24780912 |
|
NCBI chr15:98,847,728...98,851,382
Ensembl chr15:98,847,718...98,851,584
|
|
G |
Tubb5 |
tubulin, beta 5 class I |
decreases expression |
EXP |
Gold analog results in decreased expression of TUBB5 protein |
CTD |
PMID:24780912 |
|
NCBI chr17:36,144,812...36,149,193
Ensembl chr17:36,144,813...36,149,198
|
|
G |
Tufm |
Tu translation elongation factor, mitochondrial |
multiple interactions |
EXP |
Gold analog results in decreased expression of and results in increased phosphorylation of TUFM protein |
CTD |
PMID:24780912 |
|
NCBI chr 7:126,086,445...126,089,903
Ensembl chr 7:126,086,533...126,089,903
|
|
G |
Txndc5 |
thioredoxin domain containing 5 |
multiple interactions |
EXP |
Gold analog results in decreased expression of and results in increased phosphorylation of TXNDC5 protein |
CTD |
PMID:24780912 |
|
NCBI chr13:38,684,242...38,712,800
Ensembl chr13:38,684,055...38,712,800
|
|
G |
Txnip |
thioredoxin interacting protein |
decreases expression |
ISO |
Gold analog results in decreased expression of TXNIP mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 3:96,465,273...96,469,173
Ensembl chr 3:96,465,273...96,469,199
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
decreases activity increases expression |
ISO |
Gold results in decreased activity of TXNRD1 protein Gold results in increased expression of TXNRD1 mRNA |
CTD |
PMID:16510263 PMID:20851179 PMID:29705079 |
|
NCBI chr10:82,669,785...82,733,558
Ensembl chr10:82,669,785...82,733,546
|
|
G |
Txnrd2 |
thioredoxin reductase 2 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of TXNRD2 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr16:18,245,167...18,297,823
Ensembl chr16:18,245,134...18,297,823
|
|
G |
Uap1l1 |
UDP-N-acteylglucosamine pyrophosphorylase 1-like 1 |
decreases expression |
EXP |
Gold analog results in decreased expression of UAP1L1 protein |
CTD |
PMID:24780912 |
|
NCBI chr 2:25,251,501...25,255,695
Ensembl chr 2:25,249,901...25,255,694
|
|
G |
Uba2 |
ubiquitin-like modifier activating enzyme 2 |
decreases expression |
ISO |
Gold results in decreased expression of UBA2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 7:33,840,121...33,868,014
Ensembl chr 7:33,840,113...33,869,024
|
|
G |
Ube2g2 |
ubiquitin-conjugating enzyme E2G 2 |
decreases expression |
ISO |
Gold analog results in decreased expression of UBE2G2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr10:77,458,155...77,481,824
Ensembl chr10:77,458,109...77,481,827
|
|
G |
Ube2h |
ubiquitin-conjugating enzyme E2H |
increases expression |
ISO |
Gold results in increased expression of UBE2H mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 6:30,211,288...30,304,538
Ensembl chr 6:30,211,288...30,304,538
|
|
G |
Ube2n |
ubiquitin-conjugating enzyme E2N |
decreases expression |
ISO |
Gold results in decreased expression of UBE2N mRNA |
CTD |
PMID:25523186 |
|
NCBI chr10:95,351,024...95,381,520
Ensembl chr10:95,351,007...95,381,519
|
|
G |
Ube2w |
ubiquitin-conjugating enzyme E2W (putative) |
decreases expression |
ISO |
Gold results in decreased expression of UBE2W mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:16,611,012...16,689,676
Ensembl chr 1:16,611,014...16,689,713
|
|
G |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in increased expression of UCP2 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 7:100,142,565...100,148,832
Ensembl chr 7:100,142,544...100,151,227
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
decreases expression |
ISO |
Gold analog results in decreased expression of UGT1A1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 1:88,139,681...88,147,724
Ensembl chr 1:88,139,681...88,146,719
|
|
G |
Ugt2a1 |
UDP glucuronosyltransferase 2 family, polypeptide A1 |
decreases expression |
ISO |
Gold analog results in decreased expression of UGT2A1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 5:87,607,349...87,638,730
Ensembl chr 5:87,607,349...87,638,730
|
|
G |
Ugt2b38 |
UDP glucuronosyltransferase 2 family, polypeptide B38 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of UGT2B38 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 5:87,557,798...87,572,062
Ensembl chr 5:87,557,801...87,572,062
|
|
G |
Uimc1 |
ubiquitin interaction motif containing 1 |
increases expression decreases expression |
ISO |
Gold results in increased expression of UIMC1 mRNA Gold results in decreased expression of UIMC1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr13:55,175,693...55,248,176
Ensembl chr13:55,175,693...55,248,113
|
|
G |
Upp2 |
uridine phosphorylase 2 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of UPP2 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 2:58,456,329...58,685,858
Ensembl chr 2:58,457,310...58,682,983
|
|
G |
Usp1 |
ubiquitin specific peptidase 1 |
decreases expression |
ISO |
Gold results in decreased expression of USP1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:98,812,047...98,823,780
Ensembl chr 4:98,812,047...98,823,780
|
|
G |
Usp15 |
ubiquitin specific peptidase 15 |
decreases expression |
ISO |
Gold results in decreased expression of USP15 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr10:122,940,911...123,032,924
Ensembl chr10:122,940,911...123,032,900
|
|
G |
Usp16 |
ubiquitin specific peptidase 16 |
decreases expression |
ISO |
Gold results in decreased expression of USP16 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr16:87,251,833...87,280,403
Ensembl chr16:87,251,591...87,280,405
|
|
G |
Usp33 |
ubiquitin specific peptidase 33 |
decreases expression |
ISO |
Gold results in decreased expression of USP33 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:152,051,797...152,099,254
Ensembl chr 3:152,052,115...152,099,254
|
|
G |
Usp5 |
ubiquitin specific peptidase 5 (isopeptidase T) |
decreases expression |
EXP |
Gold analog results in decreased expression of USP5 protein |
CTD |
PMID:24780912 |
|
NCBI chr 6:124,791,982...124,806,404
Ensembl chr 6:124,791,982...124,806,447
|
|
G |
Vcl |
vinculin |
decreases expression |
EXP |
Gold analog results in decreased expression of VCL protein |
CTD |
PMID:24780912 |
|
NCBI chr14:20,979,436...21,083,744
Ensembl chr14:20,979,466...21,083,744
|
|
G |
Vim |
vimentin |
increases degradation |
ISO |
Gold analog results in increased degradation of VIM protein |
CTD |
PMID:26551149 |
|
NCBI chr 2:13,579,122...13,587,637
Ensembl chr 2:13,578,738...13,587,637
|
|
G |
Wbp4 |
WW domain binding protein 4 |
decreases expression |
ISO |
Gold results in decreased expression of WBP4 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr14:79,697,377...79,718,708
Ensembl chr14:79,697,377...79,718,960
|
|
G |
Wee1 |
WEE 1 homolog 1 (S. pombe) |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of WEE1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 7:109,721,266...109,742,506
Ensembl chr 7:109,721,253...109,742,493
|
|
G |
Xpa |
xeroderma pigmentosum, complementation group A |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in increased expression of XPA mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 4:46,175,222...46,196,317
Ensembl chr 4:46,155,347...46,196,311
|
|
G |
Xpc |
xeroderma pigmentosum, complementation group C |
decreases expression |
ISO |
Gold analog results in decreased expression of XPC mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 6:91,466,287...91,492,870
Ensembl chr 6:91,466,287...91,492,870
|
|
G |
Xrcc5 |
X-ray repair complementing defective repair in Chinese hamster cells 5 |
decreases expression |
ISO |
Gold analog results in decreased expression of XRCC5 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 1:72,346,576...72,434,112
Ensembl chr 1:72,346,586...72,434,111
|
|
G |
Yod1 |
YOD1 deubiquitinase |
decreases expression |
ISO |
Gold results in decreased expression of YOD1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:130,645,064...130,652,093
Ensembl chr 1:130,645,064...130,652,095
|
|
G |
Ywhag |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of YWHAG mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 5:135,937,233...135,963,495
Ensembl chr 5:135,937,263...135,963,470
|
|
G |
Zbtb21 |
zinc finger and BTB domain containing 21 |
decreases expression |
ISO |
Gold results in decreased expression of ZBTB21 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr16:97,746,993...97,763,850
Ensembl chr16:97,744,557...97,763,822
|
|
G |
Zbtb41 |
zinc finger and BTB domain containing 41 |
decreases expression |
ISO |
Gold results in decreased expression of ZBTB41 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:139,349,916...139,380,743
Ensembl chr 1:139,350,026...139,380,743
|
|
G |
Zc3h15 |
zinc finger CCCH-type containing 15 |
decreases expression |
ISO |
Gold results in decreased expression of ZC3H15 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:83,474,922...83,494,961
Ensembl chr 2:83,474,779...83,494,966
|
|
G |
Zcchc10 |
zinc finger, CCHC domain containing 10 |
decreases expression |
ISO |
Gold results in decreased expression of ZCCHC10 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr11:53,215,516...53,224,128
Ensembl chr11:53,215,506...53,224,128
|
|
G |
Zcchc9 |
zinc finger, CCHC domain containing 9 |
decreases expression |
ISO |
Gold results in decreased expression of ZCCHC9 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr13:91,944,652...91,955,824
Ensembl chr13:91,944,652...91,955,824
|
|
G |
Zcrb1 |
zinc finger CCHC-type and RNA binding motif 1 |
decreases expression |
ISO |
Gold results in decreased expression of ZCRB1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr15:93,283,987...93,296,218
Ensembl chr15:93,283,978...93,296,215
|
|
G |
Zdhhc17 |
zinc finger, DHHC domain containing 17 |
decreases expression |
ISO |
Gold results in decreased expression of ZDHHC17 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr10:110,777,640...110,848,587
Ensembl chr10:110,777,641...110,846,001
|
|
G |
Zdhhc20 |
zinc finger, DHHC domain containing 20 |
decreases expression |
ISO |
Gold results in decreased expression of ZDHHC20 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr14:58,070,159...58,128,288
Ensembl chr14:58,070,160...58,127,733
|
|
G |
Zfand1 |
zinc finger, AN1-type domain 1 |
decreases expression |
ISO |
Gold results in decreased expression of ZFAND1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:10,405,013...10,416,383
Ensembl chr 3:10,405,013...10,416,377
|
|
G |
Zfand6 |
zinc finger, AN1-type domain 6 |
decreases expression |
ISO |
Gold results in decreased expression of ZFAND6 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 7:84,264,253...84,339,224
Ensembl chr 7:84,262,974...84,339,167
|
|
G |
Zfp277 |
zinc finger protein 277 |
decreases expression |
ISO |
Gold results in decreased expression of ZNF277 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr12:40,365,045...40,495,789
Ensembl chr12:40,365,045...40,495,901
|
|
G |
Zfp422 |
zinc finger protein 422 |
decreases expression |
ISO |
Gold results in decreased expression of ZNF22 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 6:116,600,977...116,605,960
Ensembl chr 6:116,600,977...116,605,960
|
|
G |
Zfyve16 |
zinc finger, FYVE domain containing 16 |
decreases expression |
ISO |
Gold results in decreased expression of ZFYVE16 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr13:92,624,257...92,667,318
Ensembl chr13:92,623,616...92,667,376
|
|
G |
Zmpste24 |
zinc metallopeptidase, STE24 |
decreases expression |
ISO |
Gold results in decreased expression of ZMPSTE24 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 4:120,916,434...120,955,452
Ensembl chr 4:120,916,434...120,955,438
|
|
G |
Zranb2 |
zinc finger, RAN-binding domain containing 2 |
decreases expression |
ISO |
Gold results in decreased expression of ZRANB2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:157,239,749...157,254,029
Ensembl chr 3:157,239,797...157,254,047
|
|
G |
Zup1 |
zinc finger containing ubiquitin peptidase 1 |
decreases expression |
ISO |
Gold results in decreased expression of ZUP1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr10:33,795,138...33,827,316
Ensembl chr10:33,795,138...33,827,265
|
|
|
G |
Akt1 |
thymoma viral proto-oncogene 1 |
multiple interactions |
ISO |
Auranofin promotes the reaction [arsenite results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:36343453 |
|
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
|
|
G |
Alb |
albumin |
affects binding |
ISO |
Auranofin analog binds to ALB protein |
CTD |
PMID:16791640 |
|
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
multiple interactions increases response to substance |
EXP |
[BAX co-treated with BAK1] results in increased susceptibility to Auranofin; BAK1 mutant form inhibits the reaction [Auranofin results in increased activity of CASP3 protein] BAK1 results in increased susceptibility to Auranofin |
CTD |
PMID:18789312 PMID:21172426 |
|
NCBI chr17:27,238,786...27,247,601
Ensembl chr17:27,238,784...27,247,983
|
|
G |
Bax |
BCL2-associated X protein |
multiple interactions increases response to substance |
EXP |
[BAX co-treated with BAK1] results in increased susceptibility to Auranofin; BAX mutant form inhibits the reaction [Auranofin results in increased activity of CASP3 protein] BAX results in increased susceptibility to Auranofin |
CTD |
PMID:18789312 PMID:21172426 |
|
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
multiple interactions |
ISO |
BCL2 protein inhibits the reaction [Auranofin results in increased activity of CASP3 protein] |
CTD |
PMID:18789312 |
|
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity |
ISO EXP |
Auranofin promotes the reaction [TNF protein results in increased activity of CASP3 protein]; Auranofin results in decreased expression of and results in increased cleavage of CASP3 protein; BCL2 protein inhibits the reaction [Auranofin results in increased activity of CASP3 protein] BAK1 mutant form inhibits the reaction [Auranofin results in increased activity of CASP3 protein]; BAX mutant form inhibits the reaction [Auranofin results in increased activity of CASP3 protein] |
CTD |
PMID:15159275 PMID:15191400 PMID:18789312 PMID:20542334 PMID:21699084 |
|
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Casp8 |
caspase 8 |
multiple interactions |
ISO |
Auranofin results in decreased expression of and results in increased cleavage of CASP8 protein |
CTD |
PMID:20542334 |
|
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
ISO |
Auranofin results in decreased expression of and results in increased cleavage of CASP9 protein |
CTD |
PMID:20542334 |
|
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
|
|
G |
Cdkn1a |
cyclin dependent kinase inhibitor 1A |
increases expression |
ISO |
Auranofin results in increased expression of CDKN1A protein |
CTD |
PMID:20542334 |
|
NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
|
|
G |
Cebpe |
CCAAT/enhancer binding protein epsilon |
multiple interactions |
ISO |
[Auranofin co-treated with Tretinoin] results in increased expression of CEBPE protein |
CTD |
PMID:15159275 |
|
NCBI chr14:54,947,823...54,949,604
Ensembl chr14:54,947,817...54,949,631
|
|
G |
Chuk |
conserved helix-loop-helix ubiquitous kinase |
multiple interactions |
EXP ISO |
Auranofin inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased activity of CHUK protein]; Auranofin inhibits the reaction [Lipopolysaccharides results in increased activity of CHUK protein] Auranofin inhibits the reaction [TNF protein results in increased activity of CHUK protein] |
CTD |
PMID:10820281 |
|
NCBI chr19:44,061,773...44,095,940
Ensembl chr19:44,061,774...44,095,919
|
|
G |
Dio1 |
deiodinase, iodothyronine, type I |
decreases activity |
ISO |
Auranofin results in decreased activity of DIO1 protein |
CTD |
PMID:34662569 |
|
NCBI chr 4:107,148,662...107,164,365
Ensembl chr 4:107,148,662...107,164,366
|
|
G |
Egf |
epidermal growth factor |
multiple interactions |
ISO |
Auranofin promotes the reaction [arsenite results in increased expression of and results in increased secretion of EGF protein] |
CTD |
PMID:36343453 |
|
NCBI chr 3:129,471,223...129,548,971
Ensembl chr 3:129,471,214...129,548,965
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
multiple interactions increases expression |
ISO |
[Peptidoglycan co-treated with Lipopolysaccharides] promotes the reaction [Auranofin results in increased expression of GPX1 protein]; Auranofin promotes the reaction [[Lipopolysaccharides co-treated with Peptidoglycan] results in increased expression of GPX1 protein] |
CTD |
PMID:21355852 |
|
NCBI chr 9:108,216,279...108,217,541
Ensembl chr 9:108,216,102...108,217,542
|
|
G |
Gsr |
glutathione reductase |
multiple interactions |
ISO |
Auranofin promotes the reaction [arsenite results in increased activity of GSR protein] |
CTD |
PMID:36343453 |
|
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
|
|
G |
H2-Aa |
histocompatibility 2, class II antigen A, alpha |
increases response to substance |
ISO |
HLA-DQA1 gene polymorphism results in increased susceptibility to Auranofin |
CTD |
PMID:11436868 |
|
NCBI chr17:34,501,718...34,506,797
Ensembl chr17:34,501,718...34,506,797
|
|
G |
H2-Eb1 |
histocompatibility 2, class II antigen E beta |
increases response to substance |
ISO |
HLA-DRB1 gene polymorphism results in increased susceptibility to Auranofin |
CTD |
PMID:11436868 |
|
NCBI chr17:34,524,841...34,535,648
Ensembl chr17:34,524,841...34,535,648
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
ISO EXP |
Auranofin results in increased expression of HMOX1 mRNA Auranofin results in increased expression of HMOX1 mRNA; Auranofin results in increased expression of HMOX1 protein |
CTD |
PMID:22008538 PMID:23942037 |
|
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
Auranofin inhibits the reaction [IL1B protein affects the localization of RELA protein]; Auranofin inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA]; Auranofin inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein] |
CTD |
PMID:10594346 |
|
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
[Auranofin co-treated with IL6 protein] results in decreased phosphorylation of IL6ST protein; [Auranofin co-treated with IL6 protein] results in decreased phosphorylation of JAK2 protein; [Auranofin co-treated with IL6 protein] results in decreased phosphorylation of STAT3 protein |
CTD |
PMID:20542334 |
|
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
Il6st |
interleukin 6 signal transducer |
multiple interactions |
ISO |
[Auranofin co-treated with IL6 protein] results in decreased phosphorylation of IL6ST protein |
CTD |
PMID:20542334 |
|
NCBI chr13:112,600,604...112,643,394
Ensembl chr13:112,600,604...112,646,620
|
|
G |
Irak1 |
interleukin-1 receptor-associated kinase 1 |
multiple interactions |
EXP |
Auranofin inhibits the reaction [lipopolysaccharide A results in increased degradation of IRAK1 protein] |
CTD |
PMID:17034761 |
|
NCBI chr X:73,057,520...73,067,527
Ensembl chr X:73,057,520...73,067,524
|
|
G |
Irf3 |
interferon regulatory factor 3 |
multiple interactions |
EXP |
Auranofin inhibits the reaction [lipopolysaccharide A results in increased activity of IRF3 protein]; Auranofin inhibits the reaction [lipopolysaccharide A results in increased phosphorylation of IRF3 protein]; Auranofin inhibits the reaction [TBK1 protein results in increased activity of IRF3 protein]; Auranofin inhibits the reaction [TICAM1 protein results in increased activity of IRF3 protein] |
CTD |
PMID:17034761 |
|
NCBI chr 7:44,647,072...44,652,272
Ensembl chr 7:44,647,072...44,652,272
|
|
G |
Itgam |
integrin alpha M |
multiple interactions |
ISO |
[Auranofin co-treated with Tretinoin] results in increased expression of ITGAM protein |
CTD |
PMID:15159275 |
|
NCBI chr 7:127,661,812...127,717,663
Ensembl chr 7:127,661,812...127,717,663
|
|
G |
Jak2 |
Janus kinase 2 |
multiple interactions |
ISO |
[Auranofin co-treated with IL6 protein] results in decreased phosphorylation of JAK2 protein |
CTD |
PMID:20542334 |
|
NCBI chr19:29,229,006...29,290,495
Ensembl chr19:29,229,228...29,290,480
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
multiple interactions |
ISO |
Auranofin promotes the reaction [arsenite results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:36343453 |
|
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
multiple interactions |
ISO |
Auranofin promotes the reaction [arsenite results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:36343453 |
|
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
ISO |
Auranofin promotes the reaction [arsenite results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:36343453 |
|
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
|
|
G |
Mcl1 |
myeloid cell leukemia sequence 1 |
multiple interactions decreases expression |
ISO |
[Auranofin co-treated with SN50 peptide] results in decreased expression of MCL1 protein Auranofin results in decreased expression of MCL1 protein |
CTD |
PMID:20542334 |
|
NCBI chr 3:95,564,017...95,583,553
Ensembl chr 3:95,566,099...95,570,487
|
|
G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
multiple interactions |
ISO |
Auranofin promotes the reaction [arsenite results in increased expression of NFE2L2 protein] |
CTD |
PMID:36343453 |
|
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
|
|
G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
multiple interactions |
EXP |
Auranofin inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein] |
CTD |
PMID:10820281 |
|
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
|
|
G |
Nfkbib |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, beta |
multiple interactions |
EXP |
Auranofin inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIB protein] |
CTD |
PMID:10820281 |
|
NCBI chr 7:28,457,676...28,466,069
Ensembl chr 7:28,457,676...28,466,937
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
decreases activity increases cleavage |
ISO |
Auranofin results in decreased activity of PARP1 protein Auranofin results in increased cleavage of PARP1 protein |
CTD |
PMID:15159275 PMID:21370912 |
|
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
|
|
G |
Ppif |
peptidylprolyl isomerase F (cyclophilin F) |
increases oxidation multiple interactions |
ISO |
Auranofin results in increased oxidation of PPIF protein Auranofin inhibits the reaction [[NADP co-treated with TXNRD1 protein] results in increased activity of PPIF protein]; Cyclosporine promotes the reaction [Auranofin results in increased oxidation of PPIF protein] |
CTD |
PMID:26975474 |
|
NCBI chr14:25,693,998...25,700,892
Ensembl chr14:25,694,578...25,700,892
|
|
G |
Prdx3 |
peroxiredoxin 3 |
increases oxidation multiple interactions |
EXP ISO |
Auranofin results in increased oxidation of PRDX3 protein Cyclosporine promotes the reaction [Auranofin results in increased oxidation of PRDX3 protein] Auranofin promotes the reaction [[Lipopolysaccharides co-treated with Peptidoglycan] results in increased expression of PRDX3 protein] |
CTD |
PMID:18789312 PMID:21355852 PMID:26975474 |
|
NCBI chr19:60,852,504...60,862,976
Ensembl chr19:60,852,489...60,862,994
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
EXP ISO |
[lipopolysaccharide A co-treated with Auranofin] results in decreased expression of PTGS2 protein Auranofin inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA]; Auranofin inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein] |
CTD |
PMID:10594346 PMID:17034761 |
|
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
decreases phosphorylation |
ISO |
Auranofin results in decreased phosphorylation of RB1 protein |
CTD |
PMID:20542334 |
|
NCBI chr14:73,430,298...73,563,446
Ensembl chr14:73,421,113...73,563,262
|
|
G |
Rbms3 |
RNA binding motif, single stranded interacting protein |
affects response to substance |
ISO |
RBMS3 protein affects the susceptibility to Auranofin |
CTD |
PMID:36414028 |
|
NCBI chr 9:116,401,814...117,869,900
Ensembl chr 9:116,401,814...117,701,749
|
|
G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
multiple interactions |
ISO |
Auranofin inhibits the reaction [IL1B protein affects the localization of RELA protein]; Auranofin promotes the reaction [arsenite results in increased phosphorylation of RELA protein] |
CTD |
PMID:10594346 PMID:36343453 |
|
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
|
|
G |
Slc22a2 |
solute carrier family 22 (organic cation transporter), member 2 |
multiple interactions |
ISO |
Auranofin inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr17:12,803,076...12,847,376
Ensembl chr17:12,803,019...12,847,375
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
decreases expression multiple interactions |
ISO |
Auranofin results in decreased expression of STAT3 protein modified form [Auranofin co-treated with IL6 protein] results in decreased phosphorylation of STAT3 protein |
CTD |
PMID:20542334 |
|
NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366
|
|
G |
Tbk1 |
TANK-binding kinase 1 |
multiple interactions |
EXP |
Auranofin inhibits the reaction [TBK1 protein results in increased activity of IRF3 protein] |
CTD |
PMID:17034761 |
|
NCBI chr10:121,382,360...121,422,699
Ensembl chr10:121,382,360...121,422,692
|
|
G |
Tgfa |
transforming growth factor alpha |
multiple interactions |
ISO |
Auranofin promotes the reaction [arsenite results in increased expression of and results in increased secretion of TGFA protein] |
CTD |
PMID:36343453 |
|
NCBI chr 6:86,172,020...86,252,726
Ensembl chr 6:86,172,205...86,252,701
|
|
G |
Ticam1 |
TIR domain containing adaptor molecule 1 |
multiple interactions |
EXP |
Auranofin inhibits the reaction [TICAM1 protein results in increased activity of IRF3 protein] |
CTD |
PMID:17034761 |
|
NCBI chr17:56,576,462...56,583,767
Ensembl chr17:56,576,319...56,583,786
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions |
EXP |
Auranofin inhibits the reaction [lipopolysaccharide A promotes the reaction [TLR4 protein binds to TLR4 protein]] |
CTD |
PMID:17034761 |
|
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO EXP |
Auranofin inhibits the reaction [TNF protein results in increased activity of CHUK protein]; Auranofin promotes the reaction [TNF protein results in increased activity of CASP3 protein] Auranofin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA] |
CTD |
PMID:10820281 PMID:18789312 |
|
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
G |
Txn1 |
thioredoxin 1 |
increases oxidation multiple interactions |
ISO |
Auranofin results in increased oxidation of TXN protein Auranofin inhibits the reaction [arsenite results in increased expression of TXN protein] |
CTD |
PMID:26975474 PMID:36343453 |
|
NCBI chr 4:57,943,373...57,956,411
Ensembl chr 4:57,943,373...57,956,411
|
|
G |
Txn2 |
thioredoxin 2 |
increases oxidation multiple interactions |
ISO |
Auranofin results in increased oxidation of TXN2 protein Cyclosporine promotes the reaction [Auranofin results in increased oxidation of TXN2 protein] |
CTD |
PMID:26975474 |
|
NCBI chr15:77,799,251...77,813,194
Ensembl chr15:77,799,247...77,813,206
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
multiple interactions decreases activity increases oxidation increases expression |
ISO |
Auranofin inhibits the reaction [arsenite results in increased expression of and results in increased activity of TXNRD1 protein]; Auranofin inhibits the reaction [Sodium Selenite results in increased activity of TXNRD1 protein]; Auranofin promotes the reaction [Sodium Selenite results in increased expression of TXNRD1 mRNA]; potassium tellurate(IV) promotes the reaction [Auranofin results in increased oxidation of TXNRD1 protein]; Sodium Selenite promotes the reaction [Auranofin results in increased oxidation of TXNRD1 protein] Auranofin inhibits the reaction [[NADP co-treated with TXNRD1 protein] results in increased activity of PPIF protein]; Auranofin inhibits the reaction [[TXNRD1 protein co-treated with NADP] results in increased abundance of Superoxides] Auranofin results in decreased activity of TXNRD1 protein Auranofin results in increased expression of TXNRD1 mRNA |
CTD |
PMID:16510263 PMID:18405881 PMID:18789312 PMID:19486940 PMID:20457604 PMID:21172426 PMID:26975474 PMID:36343453 More...
|
|
NCBI chr10:82,669,785...82,733,558
Ensembl chr10:82,669,785...82,733,546
|
|
G |
Txnrd2 |
thioredoxin reductase 2 |
multiple interactions decreases activity |
ISO |
Auranofin inhibits the reaction [Sodium Selenite results in increased activity of TXNRD2 protein]; Auranofin promotes the reaction [Sodium Selenite results in decreased expression of TXNRD2 mRNA] Auranofin results in decreased activity of TXNRD2 protein |
CTD |
PMID:15458826 PMID:19486940 PMID:21172426 PMID:21355852 |
|
NCBI chr16:18,245,167...18,297,823
Ensembl chr16:18,245,134...18,297,823
|
|
|
G |
Tnf |
tumor necrosis factor |
decreases secretion |
ISO |
Topical GNP decreases secretion of Tnf protein in aqeous humor |
RGD |
PMID:23150627 |
RGD:7815044 |
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
|
G |
4931406C07Rik |
RIKEN cDNA 4931406C07 gene |
decreases expression |
ISO |
Gold results in decreased expression of C11ORF54 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 9:15,194,633...15,217,836
Ensembl chr 9:15,194,633...15,217,744
|
|
G |
Aass |
aminoadipate-semialdehyde synthase |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of AASS mRNA Gold analog results in decreased expression of AASS mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr 6:23,072,172...23,132,985
Ensembl chr 6:23,072,172...23,132,985
|
|
G |
Abcb1a |
ATP-binding cassette, sub-family B member 1A |
increases expression |
ISO |
Gold analog results in increased expression of ABCB1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
|
|
G |
Abcb4 |
ATP-binding cassette, sub-family B member 4 |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of ABCB4 mRNA Gold analog results in decreased expression of ABCB4 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr 5:8,943,614...9,009,226
Ensembl chr 5:8,943,717...9,009,231
|
|
G |
Abcc1 |
ATP-binding cassette, sub-family C member 1 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of ABCC1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr16:14,179,317...14,292,743
Ensembl chr16:14,179,422...14,293,601
|
|
G |
Abcc2 |
ATP-binding cassette, sub-family member 2 |
increases expression |
ISO |
Gold analog results in increased expression of ABCC2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr19:43,770,747...43,826,771
Ensembl chr19:43,770,631...43,829,179
|
|
G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of ABL1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 2:31,578,256...31,697,105
Ensembl chr 2:31,578,388...31,694,239
|
|
G |
Acaa1b |
acetyl-Coenzyme A acyltransferase 1B |
decreases expression |
ISO |
Gold analog results in decreased expression of ACAA1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 9:118,977,111...118,986,149
Ensembl chr 9:118,977,091...118,986,161
|
|
G |
Acaca |
acetyl-Coenzyme A carboxylase alpha |
decreases expression |
ISO |
Gold analog results in decreased expression of ACACA mRNA |
CTD |
PMID:36057382 |
|
NCBI chr11:84,020,461...84,292,477
Ensembl chr11:84,020,498...84,292,477
|
|
G |
Acad11 |
acyl-Coenzyme A dehydrogenase family, member 11 |
decreases expression |
ISO |
Gold analog results in decreased expression of ACAD11 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 9:103,940,923...104,004,855
Ensembl chr 9:103,940,576...104,004,924
|
|
G |
Acadm |
acyl-Coenzyme A dehydrogenase, medium chain |
decreases expression |
ISO |
Gold analog results in decreased expression of ACADM mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 3:153,627,990...153,650,280
Ensembl chr 3:153,627,994...153,650,269
|
|
G |
Acads |
acyl-Coenzyme A dehydrogenase, short chain |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of ACADS mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 5:115,248,358...115,257,405
Ensembl chr 5:115,248,358...115,257,405
|
|
G |
Acadvl |
acyl-Coenzyme A dehydrogenase, very long chain |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of ACADVL mRNA |
CTD |
PMID:28433809 |
|
NCBI chr11:69,901,009...69,906,254
Ensembl chr11:69,901,009...69,906,237
|
|
G |
Acnat2 |
acyl-coenzyme A amino acid N-acyltransferase 2 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of ACNAT2 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 4:49,374,458...49,408,151
Ensembl chr 4:49,379,840...49,408,151
|
|
G |
Aco1 |
aconitase 1 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in increased expression of ACO1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 4:40,143,429...40,199,011
Ensembl chr 4:40,143,081...40,198,338
|
|
G |
Aco2 |
aconitase 2, mitochondrial |
decreases expression multiple interactions |
EXP ISO |
Gold analog results in decreased expression of ACO2 protein [Polyethyleneimine binds to Gold] which results in increased expression of ACO2 mRNA |
CTD |
PMID:24780912 PMID:28433809 |
|
NCBI chr15:81,756,664...81,799,338
Ensembl chr15:81,756,510...81,799,334
|
|
G |
Acox1 |
acyl-Coenzyme A oxidase 1, palmitoyl |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of ACOX1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr11:116,062,714...116,089,605
Ensembl chr11:116,062,714...116,089,871
|
|
G |
Acox2 |
acyl-Coenzyme A oxidase 2, branched chain |
decreases expression |
ISO |
Gold analog results in decreased expression of ACOX2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr14:14,210,406...14,244,262
Ensembl chr14:14,210,420...14,244,262
|
|
G |
Acp1 |
acid phosphatase 1, soluble |
decreases expression |
ISO |
Gold results in decreased expression of ACP1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr12:30,943,325...30,961,616
Ensembl chr12:30,943,325...30,961,588
|
|
G |
Acvr1c |
activin A receptor, type IC |
decreases expression |
ISO |
Gold results in decreased expression of ACVR1C mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:58,157,465...58,247,909
Ensembl chr 2:58,157,465...58,247,907
|
|
G |
Adam28 |
a disintegrin and metallopeptidase domain 28 |
increases expression |
ISO |
Gold results in increased expression of ADAM28 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr14:68,842,447...68,893,338
Ensembl chr14:68,843,476...68,893,291
|
|
G |
Adh5 |
alcohol dehydrogenase 5 (class III), chi polypeptide |
decreases expression |
ISO |
Gold results in decreased expression of ADH5 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:138,142,961...138,161,260
Ensembl chr 3:138,148,854...138,161,260
|
|
G |
Adipor2 |
adiponectin receptor 2 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of ADIPOR2 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 6:119,330,111...119,394,489
Ensembl chr 6:119,330,111...119,394,665
|
|
G |
Adra1b |
adrenergic receptor, alpha 1b |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of ADRA1B mRNA |
CTD |
PMID:19695318 |
|
NCBI chr11:43,665,432...43,792,076
Ensembl chr11:43,665,433...43,792,037
|
|
G |
Adrb2 |
adrenergic receptor, beta 2 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of ADRB2 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr18:62,310,784...62,313,052
Ensembl chr18:62,310,887...62,313,030
|
|
G |
Ahsg |
alpha-2-HS-glycoprotein |
decreases expression |
ISO |
Gold analog results in decreased expression of AHSG mRNA |
CTD |
PMID:36057382 |
|
NCBI chr16:22,710,793...22,718,193
Ensembl chr16:22,710,027...22,718,199
|
|
G |
Aifm1 |
apoptosis-inducing factor, mitochondrion-associated 1 |
increases expression |
ISO |
Gold results in increased expression of AIFM1 protein |
CTD |
PMID:25462594 |
|
NCBI chr X:47,563,821...47,602,440
Ensembl chr X:47,563,821...47,602,440
|
|
G |
Aimp1 |
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 |
decreases expression |
ISO |
Gold results in decreased expression of AIMP1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:132,366,259...132,390,151
Ensembl chr 3:132,366,242...132,390,131
|
|
G |
Ak3 |
adenylate kinase 3 |
decreases expression |
ISO |
Gold results in decreased expression of AK3 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr19:28,968,715...29,026,122
Ensembl chr19:28,998,233...29,025,361
|
|
G |
Akap13 |
A kinase anchor protein 13 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of AKAP13 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 7:75,105,271...75,404,357
Ensembl chr 7:75,105,282...75,404,357
|
|
G |
Akr1b10 |
aldo-keto reductase family 1, member B10 |
increases expression |
ISO |
Gold results in increased expression of AKR1B10 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 6:34,361,182...34,373,884
Ensembl chr 6:34,361,153...34,373,885
|
|
G |
Akr1c18 |
aldo-keto reductase family 1, member C18 |
increases expression |
ISO |
Gold results in increased expression of AKR1C3 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr13:4,182,614...4,200,645
Ensembl chr13:4,182,614...4,200,653
|
|
G |
Akr1c21 |
aldo-keto reductase family 1, member C21 |
increases expression |
ISO |
Gold results in increased expression of AKR1C2 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr13:4,624,074...4,636,542
Ensembl chr13:4,624,074...4,636,540
|
|
G |
Akt1 |
thymoma viral proto-oncogene 1 |
multiple interactions |
ISO |
[Quercetin analog co-treated with Gold analog] results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:27470402 |
|
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
|
|
G |
Alb |
albumin |
multiple interactions increases expression |
ISO |
ALB protein results in increased uptake of [Polyethylene Glycols binds to Gold]; ALB protein results in increased uptake of [Polyethyleneimine binds to Gold]; ALB protein results in increased uptake of [Thioctic Acid binds to Gold] Gold analog results in increased expression of ALB mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
|
|
G |
Anxa5 |
annexin A5 |
increases expression |
EXP |
Gold analog results in increased expression of ANXA5 protein |
CTD |
PMID:24780912 |
|
NCBI chr 3:36,503,072...36,530,036
Ensembl chr 3:36,503,072...36,530,043
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of APAF1 mRNA; [Quercetin analog co-treated with Gold analog] results in increased expression of APAF1 protein Gold analog results in decreased expression of APAF1 mRNA |
CTD |
PMID:27470402 PMID:28433809 PMID:36057382 |
|
NCBI chr10:90,825,173...90,918,688
Ensembl chr10:90,825,173...90,918,632
|
|
G |
Apex1 |
apurinic/apyrimidinic endonuclease 1 |
decreases expression |
ISO |
Gold analog results in decreased expression of APEX1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr14:51,162,406...51,164,645
Ensembl chr14:51,162,425...51,164,596
|
|
G |
Apoa4 |
apolipoprotein A-IV |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of APOA4 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 9:46,152,142...46,154,756
Ensembl chr 9:46,151,994...46,154,757
|
|
G |
Aprt |
adenine phosphoribosyl transferase |
decreases expression |
EXP |
Gold analog results in decreased expression of APRT protein |
CTD |
PMID:24780912 |
|
NCBI chr 8:123,301,376...123,303,646
Ensembl chr 8:123,301,374...123,303,648
|
|
G |
Aqp4 |
aquaporin 4 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of AQP4 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr18:15,522,451...15,544,039
Ensembl chr18:15,522,553...15,544,039
|
|
G |
Arl1 |
ADP-ribosylation factor-like 1 |
decreases expression |
ISO |
Gold results in decreased expression of ARL1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr10:88,566,720...88,579,956
Ensembl chr10:88,566,720...88,579,956
|
|
G |
Arl5b |
ADP-ribosylation factor-like 5B |
decreases expression |
ISO |
Gold results in decreased expression of ARL5B mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:15,060,066...15,087,267
Ensembl chr 2:15,054,206...15,087,267
|
|
G |
Arsg |
arylsulfatase G |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of ARSG mRNA |
CTD |
PMID:19695318 |
|
NCBI chr11:109,364,159...109,464,156
Ensembl chr11:109,364,200...109,464,156
|
|
G |
Asah1 |
N-acylsphingosine amidohydrolase 1 |
decreases expression |
ISO |
Gold analog results in decreased expression of ASAH1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 8:41,793,683...41,850,681
Ensembl chr 8:41,793,234...41,827,810
|
|
G |
Atf1 |
activating transcription factor 1 |
decreases expression |
ISO |
Gold results in decreased expression of ATF1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr15:100,125,729...100,159,129
Ensembl chr15:100,125,700...100,159,125
|
|
G |
Atf4 |
activating transcription factor 4 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of ATF4 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr15:80,139,385...80,141,746
Ensembl chr15:80,139,385...80,141,742
|
|
G |
Atf6 |
activating transcription factor 6 |
increases cleavage |
ISO |
Gold analog results in increased cleavage of ATF6 protein |
CTD |
PMID:26551149 |
|
NCBI chr 1:170,532,026...170,696,414
Ensembl chr 1:170,532,243...170,695,340
|
|
G |
Atic |
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase |
decreases expression |
EXP |
Gold analog results in decreased expression of ATIC protein |
CTD |
PMID:24780912 |
|
NCBI chr 1:71,596,315...71,618,562
Ensembl chr 1:71,596,309...71,618,790
|
|
G |
Atl2 |
atlastin GTPase 2 |
decreases expression |
ISO |
Gold results in decreased expression of ATL2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr17:80,155,819...80,203,633
Ensembl chr17:80,155,819...80,203,552
|
|
G |
Atm |
ataxia telangiectasia mutated |
decreases expression |
ISO |
Gold analog results in decreased expression of ATM mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 9:53,348,422...53,448,125
Ensembl chr 9:53,350,449...53,448,040
|
|
G |
Atp2b1 |
ATPase, Ca++ transporting, plasma membrane 1 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of ATP2B1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr10:98,750,243...98,862,005
Ensembl chr10:98,750,268...98,862,005
|
|
G |
Atp5f1b |
ATP synthase F1 subunit beta |
multiple interactions |
EXP |
Gold analog results in increased expression of and results in decreased phosphorylation of ATP5F1B protein |
CTD |
PMID:24780912 |
|
NCBI chr10:127,919,176...127,926,257
Ensembl chr10:127,919,142...127,926,260
|
|
G |
Atp6v1g2 |
ATPase, H+ transporting, lysosomal V1 subunit G2 |
decreases expression |
ISO |
Gold analog results in decreased expression of ATP6V1G2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr17:35,453,910...35,457,743
Ensembl chr17:35,452,636...35,457,743
|
|
G |
Atr |
ataxia telangiectasia and Rad3 related |
decreases expression |
ISO |
Gold analog results in decreased expression of ATR mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 9:95,739,655...95,834,813
Ensembl chr 9:95,739,650...95,833,834
|
|
G |
Bace1 |
beta-site APP cleaving enzyme 1 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of BACE1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 9:45,749,878...45,775,694
Ensembl chr 9:45,749,878...45,775,697
|
|
G |
Bad |
BCL2-associated agonist of cell death |
multiple interactions |
ISO |
[Quercetin analog co-treated with Gold analog] results in increased expression of BAD protein |
CTD |
PMID:27470402 |
|
NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267
|
|
G |
Baiap2 |
brain-specific angiogenesis inhibitor 1-associated protein 2 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of BAIAP2 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr11:119,833,762...119,897,608
Ensembl chr11:119,833,589...119,897,608
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
increases expression |
ISO |
Gold results in increased expression of BAK1 mRNA |
CTD |
PMID:22178767 |
|
NCBI chr17:27,238,786...27,247,601
Ensembl chr17:27,238,784...27,247,983
|
|
G |
Bax |
BCL2-associated X protein |
multiple interactions increases expression |
ISO |
[[Gold results in decreased abundance of Glutathione] which results in increased abundance of Hydrogen Peroxide] which affects the localization of BAX protein; [Gold analog co-treated with Platinum] results in increased expression of BAX mRNA; [Polyethyleneimine binds to Gold] which results in decreased expression of BAX mRNA; [Quercetin analog co-treated with Gold analog] results in increased expression of BAX protein [Gold binds to NKCT1 protein, Naja kaouthia] which results in increased expression of BAX protein Gold results in increased expression of BAX mRNA |
CTD |
PMID:21621595 PMID:22178767 PMID:25846798 PMID:27470402 PMID:27836789 PMID:28433809 More...
|
|
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
|
|
G |
Bcas2 |
BCAS2 pre-mRNA processing factor |
decreases expression |
ISO |
Gold results in decreased expression of BCAS2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:103,078,971...103,086,479
Ensembl chr 3:103,078,971...103,086,482
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
multiple interactions |
ISO |
[Gold analog co-treated with Platinum] results in decreased expression of BCL2 mRNA; [Quercetin analog co-treated with Gold analog] results in decreased expression of BCL2 protein [Gold binds to NKCT1 protein, Naja kaouthia] which results in decreased expression of BCL2 protein |
CTD |
PMID:25846798 PMID:27470402 PMID:27836789 |
|
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Bcl2l1 |
BCL2-like 1 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in increased expression of BCL2L1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
|
|
G |
Bcl2l11 |
BCL2 like 11 |
decreases expression |
ISO |
Gold analog results in decreased expression of BCL2L11 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 2:127,967,958...128,004,467
Ensembl chr 2:127,967,958...128,004,467
|
|
G |
Birc2 |
baculoviral IAP repeat-containing 2 |
decreases expression |
ISO |
Gold results in decreased expression of BIRC2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 9:7,818,227...7,837,123
Ensembl chr 9:7,818,228...7,837,065
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
decreases expression |
ISO |
Gold analog results in decreased expression of BIRC3 mRNA; Gold results in decreased expression of BIRC3 mRNA |
CTD |
PMID:25523186 PMID:36057382 |
|
NCBI chr 9:7,848,698...7,873,199
Ensembl chr 9:7,848,700...7,873,187
|
|
G |
Bmal1 |
basic helix-loop-helix ARNT like 1 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of BMAL1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 7:112,777,820...112,913,333
Ensembl chr 7:112,806,672...112,913,333
|
|
G |
Bmi1 |
Bmi1 polycomb ring finger oncogene |
decreases expression |
ISO |
Gold results in decreased expression of BMI1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 2:18,681,953...18,691,440
Ensembl chr 2:18,681,829...18,691,440
|
|
G |
Brca1 |
breast cancer 1, early onset |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of BRCA1 mRNA Gold analog results in decreased expression of BRCA1 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr11:101,379,587...101,442,808
Ensembl chr11:101,379,590...101,442,781
|
|
G |
Brca2 |
breast cancer 2, early onset |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of BRCA2 mRNA Gold analog results in decreased expression of BRCA2 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr 5:150,445,759...150,493,612
Ensembl chr 5:150,446,095...150,493,794
|
|
G |
C1d |
C1D nuclear receptor co-repressor |
decreases expression |
ISO |
Gold results in decreased expression of C1D mRNA |
CTD |
PMID:25523186 |
|
NCBI chr11:17,207,547...17,219,176
Ensembl chr11:17,207,579...17,219,176
|
|
G |
C3 |
complement component 3 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of C3 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
|
|
G |
C9 |
complement component 9 |
decreases expression |
ISO |
Gold analog results in decreased expression of C9 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr15:6,474,827...6,528,306
Ensembl chr15:6,474,808...6,528,232
|
|
G |
Capza2 |
capping actin protein of muscle Z-line subunit alpha 2 |
decreases expression |
ISO |
Gold results in decreased expression of CAPZA2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 6:17,637,009...17,666,971
Ensembl chr 6:17,636,233...17,666,971
|
|
G |
Car13 |
carbonic anhydrase 13 |
decreases expression |
ISO |
Gold results in decreased expression of CA13 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:14,706,787...14,728,062
Ensembl chr 3:14,706,787...14,728,062
|
|
G |
Casp1 |
caspase 1 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in increased expression of CASP1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 9:5,298,517...5,307,281
Ensembl chr 9:5,298,508...5,307,290
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity increases cleavage increases expression |
ISO |
[[Gold results in decreased abundance of Glutathione] which results in increased abundance of Hydrogen Peroxide] which results in increased activity of CASP3 protein; [Gold analog co-treated with Platinum] results in increased activity of CASP3 protein; [Gold analog co-treated with Platinum] results in increased expression of CASP3 mRNA; [Polyethyleneimine binds to Gold] which results in increased expression of CASP3 mRNA; [Quercetin analog co-treated with Gold analog] results in increased cleavage of CASP3 protein; [Quercetin analog co-treated with Gold analog] results in increased expression of and results in increased activity of CASP3 protein; Dexamethasone promotes the reaction [Gold results in increased activity of CASP3 protein]; Etoposide promotes the reaction [Gold results in increased activity of CASP3 protein] Gold analog results in increased cleavage of CASP3 protein [Gold binds to NKCT1 protein, Naja kaouthia] which results in increased expression of CASP3 protein Gold results in increased expression of CASP3 mRNA |
CTD |
PMID:19760634 PMID:21621595 PMID:22178767 PMID:25846798 PMID:26551149 PMID:27470402 PMID:27836789 PMID:28433809 More...
|
|
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Casp4 |
caspase 4, apoptosis-related cysteine peptidase |
increases cleavage |
ISO |
Gold analog results in increased cleavage of CASP4 protein |
CTD |
PMID:26551149 |
|
NCBI chr 9:5,308,816...5,336,791
Ensembl chr 9:5,308,828...5,336,783
|
|
G |
Casp7 |
caspase 7 |
increases cleavage |
ISO |
Gold analog results in increased cleavage of CASP7 protein |
CTD |
PMID:26551149 |
|
NCBI chr19:56,382,640...56,430,780
Ensembl chr19:56,385,561...56,430,776
|
|
G |
Casp8 |
caspase 8 |
increases expression decreases expression |
ISO |
Gold results in increased expression of CASP8 mRNA Gold analog results in decreased expression of CASP8 mRNA |
CTD |
PMID:22178767 PMID:36057382 |
|
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases cleavage |
ISO |
[Gold analog co-treated with Platinum] results in increased activity of CASP9 protein; [Gold analog co-treated with Platinum] results in increased expression of CASP9 mRNA [Gold binds to NKCT1 protein, Naja kaouthia] which results in increased expression of CASP9 protein Gold analog results in increased cleavage of CASP9 protein |
CTD |
PMID:25846798 PMID:26551149 PMID:27836789 |
|
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
|
|
G |
Cat |
catalase |
multiple interactions |
EXP |
[Gold binds to NKCT1 protein, Naja kaouthia] inhibits the reaction [Diethylnitrosamine results in decreased activity of CAT protein] |
CTD |
PMID:27836789 |
|
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
|
|
G |
Cbx3 |
chromobox 3 |
decreases expression |
ISO |
Gold results in decreased expression of CBX3 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 6:51,447,596...51,460,684
Ensembl chr 6:51,447,340...51,460,684
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions increases secretion |
EXP |
[Gold co-treated with Silicon Dioxide] results in increased secretion of CCL2 protein Gold results in increased secretion of CCL2 protein |
CTD |
PMID:22155353 |
|
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
multiple interactions increases secretion |
EXP |
[Gold co-treated with Silicon Dioxide] results in increased secretion of CCL5 protein Gold results in increased secretion of CCL5 protein |
CTD |
PMID:22155353 |
|
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
|
|
G |
Ccl7 |
C-C motif chemokine ligand 7 |
multiple interactions increases secretion |
EXP |
[Gold co-treated with Silicon Dioxide] results in increased secretion of CCL7 protein Gold results in increased secretion of CCL7 protein |
CTD |
PMID:22155353 |
|
NCBI chr11:81,936,538...81,938,351
Ensembl chr11:81,936,538...81,938,351
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions |
ISO |
[Quercetin analog co-treated with Gold analog] results in decreased expression of CCND1 protein |
CTD |
PMID:27470402 |
|
NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
|
|
G |
Cct5 |
chaperonin containing TCP1 subunit 5 |
decreases expression |
EXP |
Gold analog results in decreased expression of CCT5 protein |
CTD |
PMID:24780912 |
|
NCBI chr15:31,590,946...31,601,992
Ensembl chr15:31,590,946...31,601,950
|
|
G |
Cd19 |
CD19 antigen |
increases expression |
ISO |
Gold analog results in increased expression of CD19 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 7:126,007,620...126,016,401
Ensembl chr 7:126,007,622...126,014,061
|
|
G |
Cd36 |
CD36 molecule |
decreases expression |
ISO |
Gold analog results in decreased expression of CD36 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 5:17,986,680...18,093,828
Ensembl chr 5:17,986,688...18,093,799
|
|
G |
Cd40 |
CD40 antigen |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of CD40 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
|
|
G |
Cd86 |
CD86 antigen |
decreases expression |
ISO |
Gold analog results in decreased expression of CD86 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr16:36,389,318...36,486,439
Ensembl chr16:36,424,231...36,486,443
|
|
G |
Cda |
cytidine deaminase |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of CDA mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 4:138,065,839...138,095,623
Ensembl chr 4:138,065,735...138,095,303
|
|
G |
Cdk1 |
cyclin dependent kinase 1 |
decreases expression increases expression |
ISO |
Gold results in decreased expression of CDK1 mRNA Gold results in increased expression of CDK1 mRNA |
CTD |
PMID:25523186 PMID:29705079 |
|
NCBI chr10:69,170,976...69,188,742
Ensembl chr10:69,170,976...69,188,768
|
|
G |
Cdk7 |
cyclin dependent kinase 7 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of CDK7 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr13:100,833,532...100,867,454
Ensembl chr13:100,839,139...100,867,447
|
|
G |
Cdkn1b |
cyclin dependent kinase inhibitor 1B |
multiple interactions |
ISO |
[Gold binds to Dimethyldithiocarbamate] which results in increased expression of CDKN1B protein |
CTD |
PMID:17079469 |
|
NCBI chr 6:134,897,364...134,902,488
Ensembl chr 6:134,897,364...134,902,476
|
|
G |
Cdkn2aip |
CDKN2A interacting protein |
decreases expression |
ISO |
Gold results in decreased expression of CDKN2AIP mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:48,162,379...48,166,966
Ensembl chr 8:48,162,379...48,166,967
|
|
G |
Cgrrf1 |
cell growth regulator with ring finger domain 1 |
decreases expression |
ISO |
Gold results in decreased expression of CGRRF1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr14:47,069,591...47,091,655
Ensembl chr14:47,069,582...47,091,650
|
|
G |
Chek1 |
checkpoint kinase 1 |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of CHEK1 mRNA Gold analog results in decreased expression of CHEK1 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr 9:36,619,935...36,637,897
Ensembl chr 9:36,619,778...36,638,361
|
|
G |
Chek2 |
checkpoint kinase 2 |
decreases expression |
ISO |
Gold analog results in decreased expression of CHEK2 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 5:110,987,668...111,022,006
Ensembl chr 5:110,987,845...111,022,011
|
|
G |
Chordc1 |
cysteine and histidine rich domain containing 1 |
decreases expression |
ISO |
Gold results in decreased expression of CHORDC1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 9:18,203,563...18,225,296
Ensembl chr 9:18,203,421...18,228,738
|
|
G |
Cisd1 |
CDGSH iron sulfur domain 1 |
decreases expression |
ISO |
Gold results in decreased expression of CISD1 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr10:71,166,324...71,180,679
Ensembl chr10:71,166,310...71,180,784
|
|
G |
Cldn12 |
claudin 12 |
decreases expression |
ISO |
Gold results in decreased expression of CLDN12 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 5:5,555,109...5,564,953
Ensembl chr 5:5,539,537...5,564,958
|
|
G |
Cnbp |
cellular nucleic acid binding protein |
decreases expression |
ISO |
Gold results in decreased expression of CNBP mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 6:87,819,597...87,828,088
Ensembl chr 6:87,819,597...87,828,088
|
|
G |
Cnot7 |
CCR4-NOT transcription complex, subunit 7 |
decreases expression |
ISO |
Gold results in decreased expression of CNOT7 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 8:40,945,579...40,968,888
Ensembl chr 8:40,945,581...40,968,888
|
|
G |
Col1a1 |
collagen, type I, alpha 1 |
increases expression |
EXP |
Gold analog results in increased expression of COL1A1 protein |
CTD |
PMID:24780912 |
|
NCBI chr11:94,827,050...94,843,868
Ensembl chr11:94,827,050...94,843,868
|
|
G |
Col1a2 |
collagen, type I, alpha 2 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of COL1A2 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 6:4,505,618...4,541,543
Ensembl chr 6:4,504,814...4,541,544
|
|
G |
Col3a1 |
collagen, type III, alpha 1 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of COL3A1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 1:45,350,698...45,388,866
Ensembl chr 1:45,350,698...45,388,866
|
|
G |
Commd8 |
COMM domain containing 8 |
decreases expression |
ISO |
Gold results in decreased expression of COMMD8 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 5:72,313,919...72,325,532
Ensembl chr 5:72,313,918...72,325,532
|
|
G |
Cox11 |
cytochrome c oxidase assembly protein 11, copper chaperone |
decreases expression |
ISO |
Gold results in decreased expression of COX11 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr11:90,529,010...90,536,803
Ensembl chr11:90,528,999...90,535,757
|
|
G |
Cox17 |
cytochrome c oxidase assembly protein 17, copper chaperone |
decreases expression |
ISO |
Gold results in decreased expression of COX17 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr16:38,167,332...38,173,125
Ensembl chr16:38,167,353...38,182,659
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of CPT1A mRNA |
CTD |
PMID:28433809 |
|
NCBI chr19:3,372,328...3,435,735
Ensembl chr19:3,372,334...3,435,733
|
|
G |
Cpt2 |
carnitine palmitoyltransferase 2 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of CPT2 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 4:107,761,179...107,780,786
Ensembl chr 4:107,761,178...107,780,807
|
|
G |
Crot |
carnitine O-octanoyltransferase |
decreases expression |
ISO |
Gold analog results in decreased expression of CROT mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 5:9,016,033...9,047,926
Ensembl chr 5:9,016,033...9,047,324
|
|
G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
multiple interactions increases secretion |
EXP |
[Gold co-treated with Silicon Dioxide] results in increased secretion of CSF2 protein Gold results in increased secretion of CSF2 protein |
CTD |
PMID:22155353 |
|
NCBI chr11:54,138,096...54,140,725
Ensembl chr11:54,138,097...54,140,493
|
|
G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
increases secretion multiple interactions |
EXP |
Gold results in increased secretion of CSF3 protein [Gold co-treated with Silicon Dioxide] results in increased secretion of CSF3 protein |
CTD |
PMID:22155353 |
|
NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455
|
|
G |
Ctcf |
CCCTC-binding factor |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of CTCF mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 8:106,351,135...106,409,554
Ensembl chr 8:106,363,200...106,409,554
|
|
G |
Cux1 |
cut-like homeobox 1 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of CUX1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 5:136,276,989...136,596,429
Ensembl chr 5:136,276,989...136,596,344
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
increases secretion multiple interactions |
EXP |
Gold results in increased secretion of CXCL10 protein [Gold co-treated with Silicon Dioxide] results in increased secretion of CXCL10 protein |
CTD |
PMID:22155353 |
|
NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
multiple interactions increases secretion |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of CXCL2 mRNA; [Gold co-treated with Silicon Dioxide] results in increased secretion of CXCL2 protein Gold results in increased secretion of CXCL2 protein |
CTD |
PMID:19695318 PMID:22155353 |
|
NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of CXCL1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr 5:90,933,960...90,935,952
Ensembl chr 5:90,933,962...90,937,459
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions |
ISO |
[[Gold results in decreased abundance of Glutathione] which results in increased abundance of Hydrogen Peroxide] which affects the localization of CYCS protein |
CTD |
PMID:21621595 |
|
NCBI chr 6:50,539,543...50,543,549
Ensembl chr 6:50,539,543...50,543,518
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases activity decreases expression multiple interactions |
EXP ISO |
Gold analog results in increased activity of CYP1A1 protein Gold analog results in decreased expression of CYP1A1 mRNA [Polyethyleneimine binds to Gold] which results in decreased expression of CYP1A1 mRNA |
CTD |
PMID:20193702 PMID:28433809 PMID:36057382 |
|
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
|
|
G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
increases expression |
ISO |
Gold results in increased expression of CYP24A1 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr 2:170,324,877...170,339,065
Ensembl chr 2:170,324,628...170,339,065
|
|
G |
Cyp2d22 |
cytochrome P450, family 2, subfamily d, polypeptide 22 |
multiple interactions decreases expression |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of CYP2D6 mRNA Gold analog results in decreased expression of CYP2D6 mRNA |
CTD |
PMID:28433809 PMID:36057382 |
|
NCBI chr15:82,254,728...82,264,461
Ensembl chr15:82,254,728...82,264,461
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
decreases expression |
ISO |
Gold analog results in decreased expression of CYP2E1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
|
|
G |
Cyp3a11 |
cytochrome P450, family 3, subfamily a, polypeptide 11 |
increases expression |
EXP |
Gold analog results in increased expression of CYP3A11 mRNA |
CTD |
PMID:22486372 |
|
NCBI chr 5:145,791,417...145,816,664
Ensembl chr 5:145,791,236...145,816,774
|
|
G |
Cyp7a1 |
cytochrome P450, family 7, subfamily a, polypeptide 1 |
increases expression |
ISO |
Gold analog results in increased expression of CYP7A1 mRNA |
CTD |
PMID:36057382 |
|
NCBI chr 4:6,265,612...6,275,632
Ensembl chr 4:6,265,612...6,275,633
|
|
G |
Cyth1 |
cytohesin 1 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of CYTH1 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr11:118,054,996...118,139,452
Ensembl chr11:118,022,845...118,139,386
|
|
G |
Dab2 |
disabled 2, mitogen-responsive phosphoprotein |
increases expression |
ISO |
Gold results in increased expression of DAB2 mRNA |
CTD |
PMID:29705079 |
|
NCBI chr15:6,329,269...6,470,196
Ensembl chr15:6,329,269...6,470,193
|
|
G |
Dcp2 |
decapping mRNA 2 |
decreases expression |
ISO |
Gold results in decreased expression of DCP2 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr18:44,513,567...44,558,036
Ensembl chr18:44,513,569...44,558,036
|
|
G |
Ddc |
dopa decarboxylase |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of DDC mRNA |
CTD |
PMID:19695318 |
|
NCBI chr11:11,764,101...11,848,144
Ensembl chr11:11,764,101...11,848,144
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in increased expression of DDIT3 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157 Ensembl chr10:127,126,643...127,132,157
|
|
G |
Ddit4 |
DNA-damage-inducible transcript 4 |
multiple interactions |
EXP |
[Gold co-treated with Polyethylene Glycols] results in increased expression of DDIT4 mRNA |
CTD |
PMID:19695318 |
|
NCBI chr10:59,785,497...59,787,592
Ensembl chr10:59,785,491...59,787,656
|
|
G |
Defb1 |
defensin beta 1 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in decreased expression of DEFB1 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr 8:22,266,571...22,285,201
Ensembl chr 8:22,266,615...22,285,201
|
|
G |
Dhcr24 |
24-dehydrocholesterol reductase |
multiple interactions decreases expression |
EXP ISO |
[Gold co-treated with Polyethylene Glycols] results in decreased expression of DHCR24 mRNA Gold analog results in decreased expression of DHCR24 mRNA [Polyethyleneimine binds to Gold] which results in decreased expression of DHCR24 mRNA |
CTD |
PMID:19695318 PMID:28433809 PMID:36057382 |
|
NCBI chr 4:106,418,279...106,446,310
Ensembl chr 4:106,418,235...106,446,310
|
|
G |
Dld |
dihydrolipoamide dehydrogenase |
decreases expression |
ISO |
Gold analog results in decreased expression of DLD mRNA |
CTD |
PMID:36057382 |
|
NCBI chr12:31,381,561...31,401,470
Ensembl chr12:31,381,276...31,401,452
|
|
G |
Dnah14 |
dynein, axonemal, heavy chain 14 |
decreases expression |
ISO |
Gold results in decreased expression of DNAH14 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 1:181,404,158...181,642,306
Ensembl chr 1:181,404,124...181,643,339
|
|
G |
Dnaja3 |
DnaJ heat shock protein family (Hsp40) member A3 |
multiple interactions |
ISO |
[Polyethyleneimine binds to Gold] which results in increased expression of DNAJA3 mRNA |
CTD |
PMID:28433809 |
|
NCBI chr16:4,501,934...4,525,559
Ensembl chr16:4,457,853...4,525,559
|
|
G |
Dnajb14 |
DnaJ heat shock protein family (Hsp40) member B14 |
decreases expression |
ISO |
Gold results in decreased expression of DNAJB14 mRNA |
CTD |
PMID:25523186 |
|
NCBI chr 3:137,572,801...137,619,350
Ensembl chr 3:137,573,436...137,622,318
|
| |